Thus O
, O
in O
V O
. O
furnissii O
, O
the O
E B
. I
coli I
manX I
equivalent I
comprises O
two O
genes O
, O
which O
are O
separated O
in O
the O
genome O
by O
two O
other O
genes O
of O
the O
ptsM B
complex I
. O

A O
GT O
- O
rich O
sequence O
binding O
the O
transcription B
factor I
Sp1 I
is O
crucial O
for O
high O
expression O
of O
the O
human B
type I
VII I
collagen I
gene I
( O
COL7A1 B
) O
in O
fibroblasts O
and O
keratinocytes O
. O

It O
was O
found O
that O
Nopp140 B
binds O
primarily O
to O
the O
CK2 B
regulatory I
subunit I
, I
beta I
. O

Synergy O
between O
interferon B
- I
gamma I
and O
tumor B
necrosis I
factor I
- I
alpha I
in O
transcriptional O
activation O
is O
mediated O
by O
cooperation O
between O
signal B
transducer I
and I
activator I
of I
transcription I
1 I
and O
nuclear B
factor I
kappaB I
. O

The O
cholesterol B
7alpha I
- I
hydroxylase I
gene I
( O
CYP7A B
) O
is O
transcriptionally O
regulated O
by O
a O
number O
of O
factors O
, O
including O
hormones O
, O
bile O
acids O
, O
and O
diurnal O
rhythm O
. O

ORF3 O
encodes O
a O
putative O
periplasmic B
c I
- I
type I
cytochrome I
with O
a O
molecular O
mass O
of O
94 O
, O
000 O
Da O
and O
contains O
seven O
c O
- O
heme O
- O
binding O
motifs O
but O
shows O
no O
sequence O
homology O
to O
occ B
or O
ORF1 O
. O

It O
has O
become O
clear O
that O
there O
is O
not O
one O
mediator O
responsible O
for O
ALI O
, O
but O
rather O
a O
complex O
interplay O
exists O
between O
diverse O
proinflammatory O
( O
e O
. O
g O
. O
, O
lipopolysaccharide O
, O
complement O
products O
, O
cytocains O
, O
chemocains O
, O
reactive O
oxygen O
species O
and O
arachidonic O
acid O
products O
) O
and O
anti O
- O
inflammatory O
( O
IL B
- I
10 I
, O
IL B
- I
1 I
- I
RA I
, O
PGI2 O
) O
mediators O
. O

SYC1 B
( O
suppressor B
of I
yeast I
cbf5 I
- I
1 I
) O
was O
identified O
as O
a O
multicopy O
suppressor O
of O
cbf5 B
- I
1 I
and O
subsequently O
was O
found O
to O
be O
identical O
to O
RRN3 B
, O
an O
RNA B
polymerase I
I I
transcription I
factor I
. O

The O
zinc B
finger I
protein I
A20 I
is O
a O
tumor B
necrosis I
factor I
( O
TNF B
) O
- O
and O
interleukin B
1 I
( O
IL B
- I
1 I
) O
- O
inducible O
protein O
that O
negatively O
regulates O
nuclear B
factor I
- I
kappa I
B I
( O
NF B
- I
kappaB I
) O
- O
dependent O
gene O
expression O
. O

Role O
of O
distinct O
mitogen B
- I
activated I
protein I
kinase I
pathways O
and O
cooperation O
between O
Ets B
- I
2 I
, O
ATF B
- I
2 I
, O
and O
Jun B
family I
members I
in O
human B
urokinase I
- I
type I
plasminogen I
activator I
gene I
induction O
by O
interleukin B
- I
1 I
and O
tetradecanoyl O
phorbol O
acetate O
. O

ATF6 B
, O
a O
basic B
- I
leucine I
zipper I
protein I
, O
was O
isolated O
by O
binding O
to O
SRF B
and O
in O
particular O
to O
its O
transcriptional O
activation O
domain O
. O

The O
originally O
embryonic B
gamma I
- I
globin I
locus I
duplicated O
and O
acquired O
a O
novel O
( O
fetal O
) O
pattern O
of O
expression O
in O
a O
defined O
time O
period O
( O
55 O
- O
40 O
million O
years O
ago O
) O
during O
primate O
phylogeny O
. O

Recombinant O
protein O
encoded O
by O
ESX B
( O
for O
epithelial B
- I
restricted I
with I
serine I
box I
) O
exhibits O
Ets B
- I
like I
DNA O
binding O
specificity O
in O
electrophoretic O
mobility O
shift O
assays O
and O
, O
in O
transient O
transfection O
assays O
, O
transactivates O
Ets B
- I
responsive I
promoter I
elements I
including O
that O
found O
in O
the O
HER2 B
/ O
neu B
oncogene O
. O

We O
constructed O
a O
stable O
, O
doubly O
transfected O
cell O
line O
( O
TIS O
- O
10 O
) O
carrying O
a O
chromosomally O
integrated O
ptetO7 B
- I
CMV I
- I
L I
reporter O
construct O
and O
expressing O
the O
TetR B
- O
KRAB B
protein O
. O

Fig1p B
and O
Fig2p B
are O
likely O
to O
act O
at O
the O
cell O
surface O
as O
Fig1 B
: O
: O
beta B
- I
gal I
and O
Fig2 B
: O
: O
beta B
- I
gal I
fusion I
proteins I
localize O
to O
the O
periphery O
of O
mating O
cells O
. O

Consistent O
with O
the O
large O
pocket O
of O
Rb B
binding O
to O
TAF B
( I
II I
) I
250 I
, O
the O
large O
pocket O
domains O
of O
both O
p107 B
and O
p130 B
are O
able O
to O
bind O
to O
TAF B
( I
II I
) I
250 I
in O
vivo O
. O

Consistent O
with O
the O
large O
pocket O
of O
Rb B
binding O
to O
TAF B
( I
II I
) I
250 I
, O
the O
large O
pocket O
domains O
of O
both O
p107 B
and O
p130 B
are O
able O
to O
bind O
to O
TAF B
( I
II I
) I
250 I
in O
vivo O
. O

The O
interleukin B
- I
2 I
receptor I
alpha I
( O
IL B
- I
2R I
alpha I
) O
chain O
gene O
contains O
a O
sequence O
similar O
to O
the O
immunoglobulin B
( I
Ig I
) I
kappa I
( O
kappa O
) O
enhancer O
NF B
- I
kappa I
B I
binding I
site I
. O

The O
interleukin B
- I
2 I
receptor I
alpha I
( O
IL B
- I
2R I
alpha I
) O
chain O
gene O
contains O
a O
sequence O
similar O
to O
the O
immunoglobulin B
( I
Ig I
) I
kappa I
( O
kappa O
) O
enhancer O
NF B
- I
kappa I
B I
binding I
site I
. O

Although O
mutant B
pex5delta I
cells O
expressing O
a O
yeast B
/ I
tobacco I
Pex5p I
chimaera I
failed O
to O
import O
a O
GFP B
- O
Eci1p B
reporter O
protein O
, O
they O
were O
able O
to O
grow O
on O
oleic O
acid O
. O

Vk8 B
/ O
Jk2 B
and O
Vk1 B
/ O
Jk5 B
rearrangements O
encoded O
the O
respective O
L B
chain I
V I
- I
regions I
. O

The O
library O
will O
thus O
be O
useful O
for O
the O
selection O
of O
cosmid O
clones O
which O
carry O
CDC B
genes I
from I
yeast I
by O
complementing O
first O
, O
with O
the O
vectorial O
yeast B
gene I
URA1 I
, O
the O
pyrimidine O
auxotrophy O
of O
most O
cdc B
- O
strains O
and O
then O
, O
with O
the O
respective O
CDC B
wild I
- I
type I
genes I
, O
of O
the O
temperature O
- O
sensitive O
mutant O
alleles O
. O

In O
addition O
, O
both O
activated O
Ral B
- I
GDS I
- I
like I
factor O
and O
Raf B
stimulate O
cyclin B
D I
( I
1 I
) I
transcription O
and O
E2F B
activity O
and O
act O
in O
synergy O
with O
PI B
3 I
- I
kinase I
. O

In O
addition O
, O
both O
activated O
Ral B
- I
GDS I
- I
like I
factor O
and O
Raf B
stimulate O
cyclin B
D I
( I
1 I
) I
transcription O
and O
E2F B
activity O
and O
act O
in O
synergy O
with O
PI B
3 I
- I
kinase I
. O

Like O
the O
DMA B
, O
but O
unlike O
all O
other O
mammalian B
class I
II I
A I
genes I
, O
the O
zebrafish O
gene O
codes O
for O
two O
cysteine O
residues O
which O
might O
potentially O
be O
involved O
in O
the O
formation O
of O
a O
disulfide O
bond O
in O
the O
alpha O
1 O
domain O
. O

Down O
- O
regulation O
of O
Id1 B
mRNA I
correlated O
with O
mitogenesis O
and O
occurred O
when O
quiescent O
cells O
were O
treated O
with O
growth O
factors O
that O
activate O
G B
protein I
- I
coupled I
receptors I
and O
receptor B
protein I
tyrosine I
kinases I
but O
not O
with O
a O
non O
- O
mitogenic O
cAMP O
analog O
. O

A O
structural O
model O
for O
Vpu B
is O
proposed O
in O
which O
the O
membrane O
anchor O
precedes O
a O
region O
comprising O
two O
amphipathic O
alpha O
- O
helices O
of O
opposed O
polarity O
, O
joined O
by O
a O
strongly O
acidic O
turn O
that O
protrudes O
into O
the O
cytoplasm O
and O
contains O
the O
CK B
- I
2 I
phosphorylation I
sites I
. O

Thus O
, O
CARP B
is O
a O
YB B
- I
1 I
associated I
factor I
and O
represents O
the O
first O
identified O
cardiac O
- O
restricted O
downstream O
regulatory O
gene O
in O
the O
homeobox O
gene O
Nkx2 B
- I
5 I
pathway O
and O
may O
serve O
as O
a O
negative O
regulator O
of O
HF B
- I
1 I
- O
dependent O
pathways O
for O
ventricular O
muscle O
gene O
expression O
. O

Each O
receptor O
must O
therefore O
engage O
a O
unique O
subset O
of O
the O
available O
signaling O
elements O
- O
- O
at O
least O
partly O
through O
the O
selection O
of O
proteins O
with O
src B
- I
homology I
2 I
domains I
( O
SH2 B
proteins I
) O
. O

Transforming B
growth I
factor I
- I
beta I
( O
TGF B
- I
beta I
) O
inhibits O
cell O
cycle O
progression O
, O
in O
part O
through O
up O
- O
regulation O
of O
gene O
expression O
of O
the O
p21 B
( O
WAF1 B
/ O
Cip1 B
) O
( O
p21 B
) O
cell O
cycle O
inhibitor O
. O

Analysis O
of O
the O
5 O
' O
and O
3 O
' O
termini O
of O
the O
transcripts O
produced O
in O
vivo O
from O
the O
puf B
operon I
of I
R I
. I
sphaeroides I
PUF B
delta I
348 I
- I
420 I
( O
three O
transcripts O
; O
0 O
. O
59 O
, O
0 O
. O
64 O
, O
and O
2 O
. O
63 O
kilobases O
) O
lacking O
the O
puf O
- O
intercistronic O
terminator O
structure O
were O
identical O
to O
those O
of O
the O
corresponding O
puf B
transcripts I
derived O
from O
wild O
- O
type O
R O
. O
sphaeroides O
2 O
. O
4 O
. O
1 O
( O
four O
transcripts O
; O
0 O
. O
50 O
, O
0 O
. O
66 O
, O
0 O
. O
71 O
, O
and O
2 O
. O
7 O
kilobases O
) O
showing O

In O
summary O
, O
FGFR3 B
signaling O
pathway O
utilizes O
two O
GRB2 B
- I
containing I
complexes I
; O
Shc B
. O
GRB2 B
. O
Sos B
and O
80K B
- I
H I
. O
pp66 B
. O
GRB2 B
. O
Sos B
; O
these O
two O
complexes O
may O
alternatively O
link O
FGFG3 B
to O
mitogen B
- I
activated I
protein I
kinase I
. O

Earlier O
published O
data O
, O
indicating O
Sp1 B
binding O
to O
the O
R1 B
alpha I
/ I
beta I
regions I
, O
could O
not O
be O
confirmed O
, O
suggesting O
that O
the O
R1 O
initiator O
element O
may O
function O
independent O
of O
Sp1 B
. O

However O
, O
and O
in O
contrast O
to O
other O
MMP B
genes I
, O
no O
significative O
synergistic O
effect O
on O
CAT B
activity O
between O
the O
AP B
- I
1 I
and O
PEA B
- I
3 I
elements I
found O
in O
the O
collagenase B
- I
3 I
gene I
promoter I
was O
found O
. O

To O
examine O
the O
effect O
of O
the O
cAMP O
signal O
transduction O
pathway O
on O
transcription O
of O
the O
gene O
encoding O
the O
catalytic O
subunit O
of O
glucose B
- I
6 I
- I
phosphatase I
( O
G6Pase B
) O
, O
G6Pase B
- O
chloramphenicol B
acetyltransferase I
( O
CAT B
) O
fusion O
genes O
were O
transiently O
transfected O
into O
either O
the O
liver O
- O
derived O
HepG2 O
or O
kidney O
- O
derived O
LLC O
- O
PK O
cell O
line O
. O

The O
STS B
sequence I
WI I
- I
14920 I
is O
in O
fact O
derived O
from O
the O
3 O
' O
- O
untranslated O
region O
of O
the O
human B
PUNC I
gene I
. O

No O
promoter O
activity O
could O
be O
detected O
with O
various O
mouse B
Fli I
- I
1 I
promoter I
- O
CAT B
constructs O
containing O
600 O
bp O
of O
the O
5 O
' O
flanking O
region O
, O
the O
complete O
exon O
1 O
, O
the O
5 O
' O
end O
of O
intron O
1 O
and O
/ O
or O
retroviral O
LTR O
sequence O
. O

The O
80 O
kb O
preceding O
the O
expression O
site O
has O
few O
, O
if O
any O
, O
functional O
ORFs O
, O
but O
contains O
50 O
bp O
repeats O
, O
INGI B
retrotransposon I
- I
like I
elements I
, O
and O
novel O
4 O
- O
12 O
kb O
repeats O
found O
near O
other O
telomeres O
. O

IRA2 B
, O
a O
second O
gene O
of O
Saccharomyces O
cerevisiae O
that O
encodes O
a O
protein O
with O
a O
domain O
homologous O
to O
mammalian O
ras B
GTPase I
- I
activating I
protein I
. O

Whereas O
mutant B
6C4 I
specified O
a O
wild B
- I
type I
- I
size I
Pol I
protein I
, O
we O
detected O
no O
full B
- I
length I
Pol I
protein I
in O
7E4 O
- O
infected O
cell O
extracts O
. O

We O
demonstrate O
that O
the O
WRM B
- I
1 I
protein I
binds O
to O
LIT B
- I
1 I
in O
vivo O
and O
that O
WRM B
- I
1 I
can O
activate O
the O
LIT B
- I
1 I
protein I
kinase I
when O
coexpressed O
in O
vertebrate O
tissue O
culture O
cells O
. O

The O
psh3 B
( I
+ I
) I
gene I
encodes O
a O
protein O
of O
215 O
amino O
acids O
, O
which O
shares O
a O
high O
degree O
of O
structural O
and O
functional O
similarity O
with O
Shr3p B
. O

The O
132 B
- I
bp I
PHO8p I
fragment I
, O
connected O
at O
position O
- O
281 O
of O
the O
5 O
' O
upstream O
region O
of O
a O
HIS5 B
' I
- O
' B
lacZ I
fused O
gene O
, O
could O
sense O
Pi O
signals O
in O
vivo O
, O
but O
a O
20 O
- O
bp O
synthetic O
oligonucleotide O
having O
the O
same O
sequence O
from O
- O
544 O
to O
- O
525 O
of O
the O
PHO8p B
DNA I
could O
not O
. O

Initial O
computer O
based O
similarity O
searches O
identified O
human B
retinoblastoma I
binding I
protein I
1 I
( O
RBP B
- I
1 I
) O
, O
Drosophila B
melanogaster I
male I
specific I
lethal I
- I
3 I
( O
Msl B
- I
3 I
) O
, O
S B
. I
pombe I
altered I
polarity I
- I
13 I
( O
Alp13 B
) O
and O
S B
. I
cerevisiae I
Eaf3p I
, O
a O
component O
of O
the O
yeast B
NuA4 I
HAT B
complex O
( O
Galarneau O
et O
al O
. O
, O
2000 O
. O

Expression O
of O
human B
complement I
receptor I
type I
2 I
( O
CR2 B
/ O
CD21 B
) O
is O
primarily O
restricted O
to O
mature O
B O
cells O
and O
follicular O
dendritic O
cells O
. O

Cloning O
the O
cDNA O
for O
a O
new O
human B
zinc I
finger I
protein I
defines O
a O
group O
of O
closely O
related O
Kruppel B
- I
like I
transcription I
factors I
. O

These O
8 B
- I
oxoguanine I
DNA I
glycosylases I
, O
hOgg1 B
( O
human O
) O
and O
mOgg1 B
( O
murine O
) O
, O
are O
homologous O
to O
each O
other O
and O
to O
yeast B
Ogg1 I
. O

Interferon B
- I
alpha I
inducibility O
of O
IFI16 B
may O
be O
regulated O
by O
an O
interferon B
- I
alpha I
/ I
beta I
- O
stimulated O
response O
consensus O
element O
in O
the O
5 O
' O
UT O
exon O
, O
as O
a O
similar O
motif O
is O
conserved O
in O
the O
corresponding O
position O
in O
the O
related O
myeloid B
cell I
nuclear I
differentiation I
antigen I
gene O
. O
( O
ABSTRACT O
TRUNCATED O
AT O
400 O
WORDS O
) O

Interferon B
- I
alpha I
inducibility O
of O
IFI16 B
may O
be O
regulated O
by O
an O
interferon B
- I
alpha I
/ I
beta I
- O
stimulated O
response O
consensus O
element O
in O
the O
5 O
' O
UT O
exon O
, O
as O
a O
similar O
motif O
is O
conserved O
in O
the O
corresponding O
position O
in O
the O
related O
myeloid B
cell I
nuclear I
differentiation I
antigen I
gene O
. O
( O
ABSTRACT O
TRUNCATED O
AT O
400 O
WORDS O
) O

Antisense O
oligonucleotides O
complementary O
to O
the O
5 O
' O
end O
of O
PKC B
- I
zeta I
mRNA I
sequences I
significantly O
reduced O
the O
collagen B
lattice O
- O
stimulated O
alpha2 O
and O
MMP B
- I
1 I
mRNA I
levels O
. O

Next O
, O
to O
examine O
the O
regulation O
mechanism O
of O
CD44 B
/ O
ERM B
interaction O
in O
vivo O
, O
we O
reexamined O
the O
immunoprecipitated O
CD44 B
/ O
ERM B
complex O
from O
BHK O
cells O
and O
found O
that O
it O
contains O
Rho B
- I
GDP I
dissociation I
inhibitor I
( O
GDI B
) O
, O
a O
regulator O
of O
Rho B
GTPase I
. O

Through O
genomic O
library O
screening O
and O
PCR O
- O
based O
genomic O
walking O
we O
have O
now O
cloned O
the O
mouse B
E I
- I
Tmod I
gene I
, O
whose O
coding O
region O
spans O
approximately O
60kb O
containing O
nine O
exons O
and O
eight O
introns O
. O

The O
TCR B
beta I
enhancer I
was O
active O
on O
both O
the O
minimal B
simian I
virus I
40 I
promoter I
and O
a O
TCR B
beta I
variable I
gene I
promoter I
in O
both O
TCR B
alpha I
/ I
beta I
+ O
and O
TCR B
gamma I
/ I
delta I
+ O
T O
cells O
. O

The O
TCR B
beta I
enhancer I
was O
active O
on O
both O
the O
minimal B
simian I
virus I
40 I
promoter I
and O
a O
TCR B
beta I
variable I
gene I
promoter I
in O
both O
TCR B
alpha I
/ I
beta I
+ O
and O
TCR B
gamma I
/ I
delta I
+ O
T O
cells O
. O

The O
WEB2 B
gene I
encodes O
a O
1 O
, O
522 O
- O
amino O
- O
acid O
protein O
with O
homology O
to O
nucleic B
acid I
- I
dependent I
ATPases I
. O

Northern O
blot O
analyses O
were O
used O
to O
examine O
the O
regulated O
expression O
of O
the O
cys B
- I
14 I
+ I
gene I
. O

Mutations O
away O
from O
splice O
site O
recognition O
sequences O
might O
cis O
- O
modulate O
alternative O
splicing O
of O
goat O
alpha B
s1 I
- I
casein I
transcripts I
. O

Inhibition O
of O
DNA B
topoisomerase I
II I
alpha I
gene I
expression O
by O
the O
p53 B
tumor I
suppressor I
. O

Both O
RNA14 B
and O
RNA15 B
wild I
- I
type I
genes I
, O
when O
cloned O
on O
a O
multicopy O
plasmid O
, O
are O
able O
to O
suppress O
the O
temperature O
- O
sensitive O
phenotype O
of O
strains O
bearing O
either O
the O
rna14 B
or O
the O
rna15 B
mutation I
, O
suggesting O
that O
the O
encoded O
proteins O
could O
interact O
with O
each O
other O
. O

This O
study O
demonstrates O
a O
novel O
link O
between O
alterations O
in O
platelet B
- I
derived I
growth I
factor I
( O
PDGF B
) O
regulation O
of O
ornithine B
decarboxylase I
( O
ODC B
) O
expression O
during O
malignant O
conversion O
. O

Second O
, O
CGGA O
- O
containing O
sequences O
placed O
at O
- O
88 O
in O
the O
delta B
MTV I
- I
CAT I
reporter I
plasmid O
conferred O
insulin B
responsiveness O
to O
the O
mammary B
tumor I
virus I
promoter I
. O

Furthermore O
, O
Grap B
is O
associated O
with O
a O
Ras B
guanine I
nucleotide I
exchange I
factor I
mSos1 B
, O
primarily O
through O
its O
N B
- I
terminal I
SH3 I
domain I
. O

Furthermore O
, O
Grap B
is O
associated O
with O
a O
Ras B
guanine I
nucleotide I
exchange I
factor I
mSos1 B
, O
primarily O
through O
its O
N B
- I
terminal I
SH3 I
domain I
. O

Association O
of O
Smads B
with O
lymphoid B
enhancer I
binding I
factor I
1 I
/ O
T B
cell I
- I
specific I
factor I
mediates O
cooperative O
signaling O
by O
the O
transforming B
growth I
factor I
- I
beta I
and O
wnt B
pathways O
. O

Association O
of O
Smads B
with O
lymphoid B
enhancer I
binding I
factor I
1 I
/ O
T B
cell I
- I
specific I
factor I
mediates O
cooperative O
signaling O
by O
the O
transforming B
growth I
factor I
- I
beta I
and O
wnt B
pathways O
. O

Association O
of O
Smads B
with O
lymphoid B
enhancer I
binding I
factor I
1 I
/ O
T B
cell I
- I
specific I
factor I
mediates O
cooperative O
signaling O
by O
the O
transforming B
growth I
factor I
- I
beta I
and O
wnt B
pathways O
. O

The O
gene O
encoding O
rat O
peptidylglycine B
alpha I
- I
amidating I
monooxygenase I
( O
PAM B
) O
contains O
26 O
protein O
- O
coding O
exons O
. O

In O
a O
previous O
study O
of O
transforming B
growth I
factor I
- I
beta1 I
- O
mediated O
inhibition O
of O
the O
cyclin B
A I
promoter I
, O
we O
mapped O
the O
inhibitory O
effect O
to O
the O
ATF B
site I
; O
in O
the O
present O
study O
of O
IFN B
- I
gamma I
treatment O
, O
functional O
analysis O
by O
transient O
transfection O
showed O
that O
inhibition O
of O
the O
cyclin B
A I
promoter I
persisted O
despite O
mutation O
of O
the O
ATF B
, O
NF B
- I
Y I
, O
or O
CDE O
elements O
. O

Analysis O
of O
the O
DNA O
- O
binding O
and O
transcriptional O
activation O
functions O
of O
human B
Fli I
- I
1 I
protein I
. O

We O
conclude O
from O
these O
observations O
that O
the O
cTnC B
3 I
' I
Ile I
element I
is O
a O
composite O
enhancer O
that O
functions O
through O
the O
combined O
interactions O
of O
at O
least O
five O
regulatory O
elements O
and O
their O
cognate O
binding O
factors O
: O
three O
or O
four O
E O
- O
boxes O
, O
a O
MEF B
- I
2 I
site I
, O
and O
a O
MEF B
- I
3 I
site I
. O

These O
findings O
suggest O
that O
the O
proteolipids O
of O
the O
vacuolar B
H I
+ I
- I
ATPases I
were O
evolved O
in O
parallel O
with O
the O
eubacterial O
proteolipid O
, O
from O
a O
common O
ancestral O
gene O
that O
underwent O
gene O
duplication O
. O

We O
conclude O
that O
the O
BR B
- I
C I
early I
gene I
directly O
activates O
late B
gene I
transcription O
by O
interacting O
with O
late B
gene I
cis O
- O
acting O
regulatory O
elements O
and O
that O
this O
interaction O
is O
responsible O
for O
the O
temporal O
linkage O
of O
early O
and O
late O
ecdysone O
- O
induced O
gene O
expression O
. O

Transient O
cotransfection O
analyses O
indicate O
that O
the O
cooperative O
association O
of O
NF B
- I
IL I
- I
6 I
and O
RelA B
with O
the O
IL B
- I
8 I
promoter I
results O
in O
synergistic O
transcriptional O
activation O
. O

We O
have O
compared O
the O
ability O
of O
GST B
- O
Bem3 B
to O
serve O
as O
a O
GAP B
for O
Cdc42Hs B
relative O
to O
other O
members O
of O
the O
rho B
- O
GAP B
subfamily O
and O
found O
the O
following O
order O
of O
potency O
: O
human B
platelet I
Cdc42Hs I
GAP I
> O
p190 B
> O
Bem3 B
> O
break B
point I
cluster I
region I
protein I
, O
whereas O
p85 B
, O
like O
Bem2 B
, O
shows O
no O
GAP B
activity O
or O
any O
ability O
to O
bind O
to O
the O
GTP O
- O
bound O
form O
of O
Cdc42Hs B
. O

Molecular O
cloning O
of O
the O
alpha B
- I
globin I
transcription I
factor I
CP2 B
. O

The O
phosphoprotein B
pUL69 I
of O
human O
cytomegalovirus O
( O
HCMV O
) O
, O
which O
is O
a O
herpesvirus O
of O
considerable O
medical O
importance O
in O
immunosuppressed O
patients O
and O
newborns O
, O
has O
previously O
been O
identified O
as O
an O
early B
- I
late I
viral I
protein I
that O
can O
stimulate O
several O
viral O
and O
cellular O
promoters O
and O
thus O
exerts O
a O
rather O
broad O
activation O
pattern O
. O

Regulation O
of O
the O
human B
stress I
response I
gene I
GADD153 I
expression O
: O
role O
of O
ETS1 B
and O
FLI B
- I
1 I
gene I
products I
. O

Regulation O
of O
the O
human B
stress I
response I
gene I
GADD153 I
expression O
: O
role O
of O
ETS1 B
and O
FLI B
- I
1 I
gene I
products I
. O

The O
PRP4 B
protein I
of I
Saccharomyces I
cerevisiae I
is O
an O
essential O
part O
of O
the O
U4 B
/ O
U6 B
snRNP O
, O
a O
component O
of O
the O
mRNA O
splicing O
apparatus O
. O

Upstream O
of O
the O
afa B
- I
3 I
gene I
cluster I
, O
a O
1 O
. O
2 O
- O
kb O
region O
was O
found O
to O
be O
96 O
% O
identical O
to O
the O
RepFIB B
sequence I
of O
one O
of O
the O
enterotoxigenic O
E O
. O
coli O
plasmids O
( O
P307 O
) O
, O
suggesting O
a O
common O
ancestor O
plasmid O
. O

Although O
analysis O
of O
the O
similarity O
between O
the O
44 O
- O
kDa O
protein O
and O
the O
E B
. I
coli I
RecA I
protein I
did O
not O
show O
any O
significant O
homology O
between O
them O
, O
it O
revealed O
their O
identity O
by O
five O
amino O
- O
acid O
residues O
involved O
in O
the O
formation O
of O
the O
epitope O
that O
recognized O
the O
paratope O
of O
the O
RecA B
protein I
antibody I
for O
subsequent O
epitope O
- O
paratope O
binding O
of O
these O
proteins O
. O

Effectively O
, O
the O
upstream O
, O
housekeeping O
- O
type O
promoter O
responds O
to O
FIXK B
and O
positively O
regulates O
the O
downstream O
, O
sigma B
54 I
- I
type I
promoter I
. O

The O
human O
sequence O
contains O
the O
element O
TGACTCT O
that O
also O
is O
found O
in O
a O
murine B
ras I
- I
responsive I
enhancer I
. O

Signal O
transduction O
in O
fibroblasts O
stably O
transformed O
by O
[ O
Val12 O
] O
Ras O
- O
- O
the O
activities O
of O
extracellular B
- I
signal I
- I
regulated I
kinase I
and O
Jun B
N I
- I
terminal I
kinase I
are O
only O
moderately O
increased O
, O
and O
the O
activity O
of O
the O
delta O
- O
inhibitor O
of O
c B
- I
Jun I
is O
not O
alleviated O
. O

We O
conclude O
that O
these O
cDNAs O
belong O
to O
a O
novel O
GST B
class O
hereby O
designated O
Kappa O
, O
with O
the O
rat B
GST I
subunit I
13 I
gene I
designated O
rGSTK1 B
and O
the O
human O
gene O
being O
called O
hGSTK1 B
. O

These O
involve O
( O
1 O
) O
subcloning O
a O
promoterless O
sucCD B
fragment I
downstream O
of O
the O
lac B
promoter I
in O
M13mp10 O
, O
and O
( O
2 O
) O
precise O
splicing O
of O
the O
suc B
coding I
regions I
with O
the O
efficient O
atpE B
ribosome I
- I
binding I
site I
and O
expression O
from O
the O
thermoinducible O
lambda O
promoters O
in O
the O
pJLA503 O
vector O
. O

Fas B
( O
APO B
- I
1 I
/ O
CD95 B
) O
, O
which O
is O
a O
member O
of O
the O
tumor B
necrosis I
factor I
receptor I
superfamily I
, O
is O
a O
cell O
surface O
receptor O
that O
induces O
apoptosis O
. O

However O
, O
a O
few O
sites O
in O
the O
genomes O
of O
EC O
cells O
permit O
M B
- I
MuLVneo I
delta I
Enh I
proviral O
expression O
. O

To O
better O
understand O
the O
relationship O
between O
expression O
of O
an O
oncogene O
and O
genetic O
instability O
, O
we O
have O
studied O
a O
cell O
line O
expressing O
an O
activated B
human I
Ha I
- I
ras I
under O
the O
control O
of O
bacterial B
lactose I
operon I
regulatory I
elements I
for O
changes O
in O
methotrexate O
resistance O
and O
dihydrofolate B
reductase I
( O
dhfr B
) O
gene O
amplification O
following O
mutant B
Ha I
- I
ras I
induction O
. O

To O
better O
understand O
the O
relationship O
between O
expression O
of O
an O
oncogene O
and O
genetic O
instability O
, O
we O
have O
studied O
a O
cell O
line O
expressing O
an O
activated B
human I
Ha I
- I
ras I
under O
the O
control O
of O
bacterial B
lactose I
operon I
regulatory I
elements I
for O
changes O
in O
methotrexate O
resistance O
and O
dihydrofolate B
reductase I
( O
dhfr B
) O
gene O
amplification O
following O
mutant B
Ha I
- I
ras I
induction O
. O

The O
antiserum O
used O
for O
immunoblotting O
specifically O
supershifts O
uteroglobin B
promoter I
- I
protein I
complexes I
in O
gel O
shift O
experiments O
. O

Drosophila B
melanogaster I
casein I
kinase I
II I
( O
DmCKII B
) O
is O
composed O
of O
catalytic O
( O
alpha O
) O
and O
regulatory O
( O
beta O
) O
subunits O
associated O
as O
an O
alpha2beta2 O
heterotetramer O
. O

Expression O
of O
these O
chemokines O
is O
similar O
in O
that O
both O
require O
the O
NF B
- I
kappa I
B I
element I
and O
additional O
regions O
such O
as O
the O
CAAT B
/ I
enhancer I
binding I
protein I
( O
C B
/ I
EBP I
) O
element O
of O
the O
IL B
- I
8 I
promoter I
. O

Expression O
of O
these O
chemokines O
is O
similar O
in O
that O
both O
require O
the O
NF B
- I
kappa I
B I
element I
and O
additional O
regions O
such O
as O
the O
CAAT B
/ I
enhancer I
binding I
protein I
( O
C B
/ I
EBP I
) O
element O
of O
the O
IL B
- I
8 I
promoter I
. O

Basal O
JNK B
MAPK I
kinase I
activity O
was O
also O
specifically O
induced O
by O
deltaEGFR B
, O
which O
correlated O
with O
increased O
phosphorylation O
of O
a O
54 B
- I
kDa I
JNK2 I
protein I
observed O
in O
deltaEGFR B
- O
containing O
cells O
. O

A O
sequence O
- O
ready O
3 O
- O
Mb O
PAC O
contig O
covering O
16 O
breakpoints O
of O
the O
Wilms B
tumor I
/ I
anirida I
region I
of O
human O
chromosome O
11p13 O
. O

RET B
/ O
PTC B
oncogenes O
, O
generated O
by O
chromosomal O
rearrangements O
in O
papillary O
thyroid O
carcinomas O
, O
are O
constitutively O
activated O
versions O
of O
proto B
- I
RET I
, O
a O
gene O
coding O
for O
a O
receptor B
- I
type I
tyrosine I
kinase I
( O
TK B
) O
whose O
ligand O
is O
still O
unknown O
. O

These O
sequences O
were O
further O
tested O
for O
the O
presence O
of O
an O
enhancer O
element O
, O
by O
their O
ability O
to O
activate O
a O
fusion O
reporter O
gene O
consisting O
of O
the O
CAT B
gene I
linked O
to O
the O
gamma B
- I
globin I
gene I
promoter I
, O
in O
erythroid O
( O
K562 O
) O
and O
non O
- O
erythroid O
( O
HeLa O
) O
cells O
. O

In O
vitro O
binding O
studies O
previously O
showed O
that O
NF B
- I
kappa I
B I
p50 B
homodimer O
binds O
the O
switch B
nuclear I
B I
- I
site I
protein I
( O
SNIP B
) O
of O
the O
S B
gamma I
3 I
tandem I
repeat I
. O

Furthermore O
, O
the O
induction O
of O
cytochrome B
P I
- I
450 I
1A1 I
observed O
in O
the O
cormorant O
indicates O
that O
the O
Ah B
receptor I
- O
mediated O
process O
, O
by O
which O
TCDD O
and O
related O
chemicals O
exert O
many O
of O
their O
toxicities O
, O
has O
been O
activated O
. O

Plasma B
colony I
- I
stimulating I
factor I
analysis O
and O
the O
clinical O
significance O

Thus O
, O
in O
addition O
to O
the O
previously O
characterized O
FAS B
- I
binding I
factor I
1 I
interacting O
with O
the O
inositol O
/ O
choline O
- O
responsive O
- O
element O
motif O
, O
a O
second O
motif O
common O
to O
the O
promoter O
regions O
of O
both O
FAS B
genes I
could O
be O
identified O
. O

In O
addition O
, O
the O
results O
suggest O
that O
N O
region O
diversity O
at O
V B
( O
D B
) O
J B
junctions O
within O
rearranged O
immunoglobulin B
and O
T B
cell I
receptor I
gene I
loci I
can O
only O
be O
introduced O
after O
the O
generation O
of O
RAG B
- O
catalyzed O
DNA O
double O
- O
strand O
breaks O
, O
i O
. O
e O
. O
during O
the O
DNA O
end O
joining O
phase O
of O
the O
V B
( O
D B
) O
J B
recombination O
reaction O
. O

To O
study O
structural O
diversity O
of O
the O
three O
homologous O
loci O
encoding O
a O
KN1 B
- I
like I
homeobox I
protein I
in O
the O
hexaploid O
wheat O
genome O
, O
we O
isolated O
clones O
from O
a O
cDNA O
library O
of O
young O
spikes O
of O
Japanese O
common O
wheat O
cultivar O
' O
Norin O
26 O
' O
. O

Like O
the O
human B
erythrocyte I
P4 I
. I
2 I
, O
mouse B
erythrocyte I
P4 I
. I
2 I
contains O
regions O
strikingly O
homologous O
with O
the O
transglutaminase O
( O
TGase O
) O
proteins O
although O
it O
too O
most O
likely O
lacks O
TGase O
crosslinking O
activity O
. O

Like O
the O
human B
erythrocyte I
P4 I
. I
2 I
, O
mouse B
erythrocyte I
P4 I
. I
2 I
contains O
regions O
strikingly O
homologous O
with O
the O
transglutaminase O
( O
TGase O
) O
proteins O
although O
it O
too O
most O
likely O
lacks O
TGase O
crosslinking O
activity O
. O

These O
three O
chromosomes O
share O
the O
transferrin B
gene I
( O
TF B
) O
, O
the O
myosin B
light I
polypeptide I
3 I
gene I
( O
MYL3 B
) O
, O
and O
the O
acylpeptide B
hydrolase I
gene I
( O
APEH B
) O
. O

Human B
myotonic I
dystrophy I
protein I
kinase I
( O
DMPK B
) O
is O
a O
member O
of O
a O
novel O
class O
of O
multidomain O
protein O
kinases O
that O
regulate O
cell O
size O
and O
shape O
in O
a O
variety O
of O
organisms O
. O

This O
mutation O
was O
associated O
with O
reduced O
or O
absent O
expression O
of O
TGF B
- I
beta I
RI I
protein I
and O
p53 B
protein I
in O
tumor O
tissues O
. O

Screening O
of O
human O
cDNA O
libraries O
has O
identified O
two O
different O
5 O
' O
- O
termini O
and O
alternatively O
spliced O
forms O
of O
the O
human B
Fli I
- I
1 I
gene I
( O
Fli B
- I
1b I
) O
, O
suggesting O
the O
possible O
existence O
of O
two O
independent O
promoters O
. O

This O
report O
describes O
the O
isolation O
and O
recombinant O
expression O
of O
a O
cDNA O
clone O
encoding O
HER4 B
, O
the O
fourth O
member O
of O
the O
human B
epidermal I
growth I
factor I
receptor I
( O
EGFR B
) O
family O
. O

MDA O
- O
MB O
- O
468 O
cells O
were O
stably O
transfected O
with O
either O
a O
plasmid O
having O
a O
CMV B
promoter I
- O
driven O
rabbit B
beta I
- I
globin I
gene I
or O
plasmids O
having O
a O
CMV B
promoter I
- O
driven O
chimeric O
gadd45 B
5 O
" O
- O
UTR O
- O
rabbit B
beta I
- I
globin I
gene O
, O
where O
the O
entire B
gadd45 I
5 I
" I
- I
UTR I
( I
from I
+ I
1 I
to I
+ I
298 I
) I
or O
a O
45 O
bp O
subfragment O
of O
the O
gadd45 B
5 I
" I
- I
UTR I
( I
from I
+ I
10 I
to I
+ I
55 I
) I
was O
positioned O
at O
the O
5 O
" O
- O
end O
of O

the O
rabbit B
beta I
- I
globin I
gene I
. O

Gel O
mobility O
shift O
analyses O
reveal O
that O
FRTL O
- O
5 O
thyroid O
cell O
nuclear O
extracts O
form O
a O
specific O
protein O
/ O
DNA O
complex O
with O
this O
region O
, O
which O
is O
prevented O
by O
the O
TTF B
- I
1 I
binding I
element I
from O
the O
TG B
promoter I
; O
FRT O
and O
BRL O
cell O
nuclear O
extracts O
do O
not O
have O
TTF B
- I
1 I
and O
do O
not O
form O
this O
complex O
. O

Comparison O
of O
the O
genes O
coding O
for O
mouse O
and O
human O
p36 B
( O
annexin B
II I
) O
and O
mouse O
, O
rat O
and O
human O
p35 B
( O
annexin B
I I
) O
and O
pigeon O
cp35 B
( O
an O
annexin B
I I
- I
related I
protein I
) O
shows O
strong O
genomic O
structural O
conservation O
supporting O
the O
hypothesis O
that O
these O
genes O
had O
a O
common O
ancestor O
. O

Further O
analysis O
of O
the O
CAP59 B
locus I
of I
Cryptococcus I
neoformans I
: O
structure O
defined O
by O
forced O
expression O
and O
description O
of O
a O
new O
ribosomal B
protein I
- I
encoding I
gene I
. O

Further O
analysis O
of O
the O
CAP59 B
locus I
of I
Cryptococcus I
neoformans I
: O
structure O
defined O
by O
forced O
expression O
and O
description O
of O
a O
new O
ribosomal B
protein I
- I
encoding I
gene I
. O

We O
have O
previously O
reported O
the O
first O
isolation O
of O
a O
c B
- I
myc I
- I
null I
cell O
line O
. O

Antibodies O
specific O
to O
the O
different O
members O
of O
the O
Jun B
and O
Fos B
family I
of I
transcription I
factors I
show O
that O
, O
in O
gel O
retardation O
assays O
, O
a O
Jun B
- I
like I
factor I
is O
a O
component O
of O
the O
H3 B
. I
2 I
specific I
complex I
. O

Antibodies O
specific O
to O
the O
different O
members O
of O
the O
Jun B
and O
Fos B
family I
of I
transcription I
factors I
show O
that O
, O
in O
gel O
retardation O
assays O
, O
a O
Jun B
- I
like I
factor I
is O
a O
component O
of O
the O
H3 B
. I
2 I
specific I
complex I
. O

Interaction O
between O
the O
tobacco O
DNA O
- O
binding O
activity O
CBF B
and O
the O
cyt B
- I
1 I
promoter I
element I
of O
the O
Agrobacterium O
tumefaciens O
T O
- O
DNA O
gene O
T B
- I
CYT I
correlates O
with O
cyt B
- I
1 I
directed O
gene O
expression O
in O
multiple O
tobacco O
tissue O
types O
. O

Ras B
involvement O
in O
signal O
transduction O
by O
the O
serotonin B
5 I
- I
HT2B I
receptor I
. O

Coexpression O
of O
a O
dominant B
negative I
c I
- I
jun I
antagonized O
the O
ras B
- O
dependent O
stimulation O
of O
the O
92 B
- I
kDa I
gelatinase I
B I
promoter O
- O
driven O
CAT B
reporter I
. O

Coexpression O
of O
a O
dominant B
negative I
c I
- I
jun I
antagonized O
the O
ras B
- O
dependent O
stimulation O
of O
the O
92 B
- I
kDa I
gelatinase I
B I
promoter O
- O
driven O
CAT B
reporter I
. O

Transcriptional O
regulation O
of O
the O
murine B
k I
- I
fgf I
gene I
. O

Candidate O
factors O
have O
been O
identified O
by O
the O
observation O
that O
changes O
in O
glucocorticoid O
induction O
parameters O
in O
CV O
- O
1 O
cells O
could O
be O
reproduced O
by O
varying O
the O
cellular O
levels O
of O
coactivators O
[ O
transcriptional B
intermediary I
factor I
2 I
( O
TIF2 B
) O
, O
steroid B
receptor I
coactivator I
1 I
( O
SRC B
- I
1 I
) O
, O
and O
amplified B
in I
breast I
cancer I
1 I
( O
AIB1 B
) O
] O
, O
comodulator O
[ O
CREB B
- I
binding I
protein I
( O
CBP B
) O
] O
, O
or O
corepressor O
[ O
silencing B
mediator I
for I
retinoid I
and I
thyroid I
- I
hormone I
receptors I
( O
SMRT B
) O
] O
without O

Our O
results O
show O
that O
a O
combination O
of O
Pfu B
exo I
( I
- I
) I
at O
the O
primer O
extension O
step O
and O
Taq B
at O
the O
PCR O
amplification O
step O
is O
ideal O
for O
in O
vivo O
DNA O
analysis O
and O
DNA O
damage O
mapping O
using O
LMPCR O
. O

Using O
lacZ B
- O
inducible O
T O
cells O
as O
a O
probe O
, O
we O
screened O
a O
splenic O
cDNA O
library O
in O
transiently O
transfected O
antigen O
- O
presenting O
cells O
( O
APCs O
) O
and O
isolated O
a O
cDNA O
clone O
that O
allowed O
expression O
of O
the O
appropriate O
peptide B
/ I
Kb I
MHC I
complex I
in O
APC O
. O

Moreover O
, O
since O
the O
integrated O
transforming O
DNA O
was O
not O
altered O
or O
lost O
expression O
of O
the O
RbcS2 B
: O
: O
aadA B
: O
: O
RbcS2 B
gene I
( I
s I
) I
appears O
to O
be O
repressed O
. O

In O
contrast O
, O
vRel B
lacks O
a O
strong O
C O
- O
terminal O
gene O
activation O
function O
, O
since O
a O
LexA B
fusion I
protein I
containing O
C B
- I
terminal I
vRel I
sequences I
alone O
only O
weakly O
activated O
transcription O
. O

The O
crystal O
structure O
of O
the O
yeast O
Phe B
- I
tRNAPhe I
ternary I
complex I
with O
Thermus O
aquaticus O
EF B
- I
Tu I
- O
GDPNP O
( O
Phe B
- I
TC I
) O
has O
previously O
been O
determined O
as O
one O
representative O
of O
this O
general O
yet O
highly O
discriminating O
complex O
formation O
. O

Base O
substitutions O
within O
this O
NFIL B
- I
6 I
site I
resulted O
in O
virtual O
elimination O
of O
LPS O
- O
induced O
IL B
- I
1 I
beta I
gene I
transcription O
. O

The O
human B
lbc I
oncogene I
product I
is O
a O
guanine B
nucleotide I
exchange I
factor I
that O
specifically O
activates O
the O
Rho B
small I
GTP I
binding I
protein I
, O
thus O
resulting O
in O
biologically O
active O
, O
GTP O
- O
bound O
Rho B
, O
which O
in O
turn O
mediates O
actin B
cytoskeletal O
reorganization O
, O
gene O
transcription O
, O
and O
entry O
into O
the O
mitotic O
S O
phase O
. O

The O
results O
of O
these O
studies O
indicate O
that O
EHV B
- I
1 I
gp13 I
is O
the O
structural O
homolog O
of O
herpes B
simplex I
virus I
glycoprotein I
C I
and O
further O
suggest O
that O
the O
epitope O
- O
containing O
N O
- O
terminal O
amino O
acid O
sequences O
of O
the O
herpesvirus B
gC I
- I
like I
glycoproteins I
have O
undergone O
more O
extensive O
evolutionary O
divergence O
than O
the O
C O
- O
terminal O
sequences O
. O

The O
results O
of O
these O
studies O
indicate O
that O
EHV B
- I
1 I
gp13 I
is O
the O
structural O
homolog O
of O
herpes B
simplex I
virus I
glycoprotein I
C I
and O
further O
suggest O
that O
the O
epitope O
- O
containing O
N O
- O
terminal O
amino O
acid O
sequences O
of O
the O
herpesvirus B
gC I
- I
like I
glycoproteins I
have O
undergone O
more O
extensive O
evolutionary O
divergence O
than O
the O
C O
- O
terminal O
sequences O
. O

; O
G6670 B
is O
identical O
to O
ORF2 O
located O
close O
to O
CYS4 B
; O
G6673 B
is O
PEM1 B
/ O
CHO2 B
encoding O
a O
phosphatidylethanolamine B
methyltransferase I
; O
G7001 B
is O
the O
NSR1 B
gene I
coding O
for O
a O
nuclear O
signal O
recognition O
protein O
. O

Recombinant B
mouse I
GSTT1 I
- I
1 I
was O
catalytically O
active O
towards O
1 O
, O
2 O
- O
epoxy O
- O
3 O
- O
( O
p O
- O
nitrophenoxy O
) O
propane O
, O
4 O
- O
nitrobenzyl O
chloride O
and O
dichloromethane O
. O

Transcripts O
appear O
to O
be O
initiated O
from O
an O
upstream O
promoter O
, O
P1 O
, O
located O
in O
front O
of O
the O
tRNA B
( I
met1 I
) I
gene I
and O
from O
three O
internal O
promoters O
: O
P2 O
is O
located O
immediately O
in O
front O
of O
the O
tRNA B
( I
met2 I
) I
gene I
; O
PL10 O
is O
near O
the O
beginning O
of O
the O
L1 B
- O
L10 B
intergenic O
space O
, O
and O
PL12 O
is O
at O
the O
end O
of O
the O
L10 B
gene I
sequence I
. O

Transcripts O
appear O
to O
be O
initiated O
from O
an O
upstream O
promoter O
, O
P1 O
, O
located O
in O
front O
of O
the O
tRNA B
( I
met1 I
) I
gene I
and O
from O
three O
internal O
promoters O
: O
P2 O
is O
located O
immediately O
in O
front O
of O
the O
tRNA B
( I
met2 I
) I
gene I
; O
PL10 O
is O
near O
the O
beginning O
of O
the O
L1 B
- O
L10 B
intergenic O
space O
, O
and O
PL12 O
is O
at O
the O
end O
of O
the O
L10 B
gene I
sequence I
. O

The O
cdc42W97R B
temperature I
- I
sensitive I
allele I
in O
S O
. O
cerevisiae O
displayed O
the O
same O
cell O
- O
division O
- O
cycle O
arrest O
phenotype O
( O
large O
, O
round O
unbudded O
cells O
) O
as O
the O
cdc42 B
- I
1ts I
mutant I
. O

Sequences O
within O
and O
flanking O
hypersensitive O
sites O
3 O
and O
2 O
of O
the O
beta B
- I
globin I
locus O
control O
region O
required O
for O
synergistic O
versus O
additive O
interaction O
with O
the O
epsilon B
- I
globin I
gene I
promoter I
. O

In O
both O
cell O
types O
, O
insulin B
led O
to O
a O
dose O
- O
dependent O
increase O
in O
the O
association O
of O
tyrosine B
phosphorylated I
IRS I
- I
1 I
with O
the O
SH2 B
domain I
of O
the O
p85 B
regulatory I
subunit I
of O
PI B
- I
3 I
kinase I
, O
and O
also O
increased O
the O
amount O
of O
PI B
kinase I
activity O
detected O
in O
anti B
- I
IRS I
- I
1 I
immunoprecipitates O
. O

In O
both O
cell O
types O
, O
insulin B
led O
to O
a O
dose O
- O
dependent O
increase O
in O
the O
association O
of O
tyrosine B
phosphorylated I
IRS I
- I
1 I
with O
the O
SH2 B
domain I
of O
the O
p85 B
regulatory I
subunit I
of O
PI B
- I
3 I
kinase I
, O
and O
also O
increased O
the O
amount O
of O
PI B
kinase I
activity O
detected O
in O
anti B
- I
IRS I
- I
1 I
immunoprecipitates O
. O

The O
Xenopus B
annexin I
II I
heavy I
chain I
lacks O
the O
highly O
conserved O
tyrosine O
at O
position O
23 O
which O
is O
the O
site O
of O
src B
oncogene I
tyrosine B
kinase I
phosphorylation O
in O
the O
murine O
protein O
. O

Plasmids O
bearing O
the O
P B
. I
stipitis I
URA3 I
gene I
and O
ARS2 O
element O
produced O
more O
than O
30 O
, O
000 O
transformants O
per O
micrograms O
of O
plasmid O
DNA O
. O

Elevated O
potassium O
stimulation O
of O
GAL B
mRNA I
was O
completely O
blocked O
, O
but O
pituitary O
adenylyl B
cyclase I
- I
activating I
polypeptide I
and O
histamine O
stimulations O
were O
only O
partially O
blocked O
, O
by O
cycloheximide O
. O

This O
enhancer O
element O
functioned O
in O
a O
position O
- O
and O
orientation O
- O
independent O
manner O
both O
on O
the O
Pax B
- I
QNR I
P0 I
promoter I
and O
the O
heterologous B
thymidine I
kinase I
promoter I
. O

Gel O
shift O
and O
southwestern O
experiments O
revealed O
nuclear O
proteins O
of O
43 O
kDa O
and O
30 O
kDa O
in O
GC O
and O
fish O
cells O
, O
respectively O
, O
that O
bind O
specifically O
to O
the O
tGH B
CRE O
, O
suggesting O
the O
involvement O
of O
CRE B
- I
binding I
- I
protein I
/ O
activating B
- I
transcription I
- I
factor I
- I
l I
- O
related O
peptides O
in O
cAMP O
response O
. O

On O
the O
basis O
of O
experiments O
with O
mutant O
virus O
and O
transfection O
with O
isolated O
genes O
, O
the O
herpes B
simplex I
virus I
immediate I
- I
early I
gene I
product O
ICP4 B
is O
known O
to O
positively O
regulate O
the O
transcription O
of O
viral B
early I
and I
late I
genes I
and O
negatively O
regulate O
expression O
from O
its O
own O
promoter O
. O

Activation O
of O
the O
mitogen B
- I
activated I
protein I
kinase I
( O
MAPK B
) O
pathway O
enhances O
long O
- O
range O
transactivation O
by O
the O
beta B
- I
globin I
locus I
control I
region I
( O
LCR O
) O
( O
W O
. O

Six O
cDNAs O
represent O
human O
homologs O
of O
genes O
known O
in O
other O
species O
, O
namely O
, O
mouse B
HSPE71 I
, O
Rat B
RhoGAP I
protein I
, O
S B
cerevisiae I
leucyl I
tRNA I
synthetase I
and O
S B
cerevisiae I
chromosome I
II I
ORF I
YBLO44W I
. O

All O
three O
SSV O
- O
transformed O
cells O
secreted O
v B
- I
sis I
gene I
product I
( O
p44 B
) O
. O

The O
DNA O
element O
through O
which O
EBNA B
- I
3C I
activates O
the O
LMP B
- I
1 I
promoter I
includes O
a O
Spi B
- I
1 I
/ O
Spi B
- I
B I
binding O
site O
, O
previously O
characterized O
as O
an O
important O
EBNA B
- I
2 I
response I
element I
. O

Finally O
, O
we O
demonstrate O
that O
animals O
carrying O
a O
snf B
mutation O
that O
converts O
SNF B
from O
a O
bifunctional O
protein O
to O
a O
U1 B
snRNP I
- I
specific I
protein I
are O
viable O
. O

Previous O
work O
established O
that O
the O
TAL1 B
proteins I
are O
phosphorylated O
exclusively O
on O
serine O
and O
identified O
Ser122 O
as O
a O
substrate O
for O
the O
mitogen B
- I
activated I
protein I
kinase I
ERK B
- I
1 I
. O

The O
induction O
of O
the O
composite O
H B
- I
PK I
/ O
Tag B
and O
SV B
- I
PK I
/ O
Tag B
transgenes O
by O
a O
carbohydrate O
- O
rich O
diet O
in O
the O
liver O
was O
similar O
to O
that O
of O
the O
endogenous B
L I
- I
PK I
gene I
. O

The O
protein O
contains O
a O
SHAQKYF O
amino O
acid O
signature O
motif O
in O
the O
second O
myb B
- I
like I
repeat I
, O
which O
is O
highly O
conserved O
in O
a O
number O
of O
recently O
identified O
plant B
myb I
- I
related I
genes I
, O
thus O
defining O
a O
new O
class O
of O
plant O
DNA O
- O
binding O
proteins O
. O

Furthermore O
, O
addition O
of O
the O
recombinant B
NF I
- I
YA I
subunit I
restores O
NF B
- I
Y I
binding O
. O

Our O
results O
suggest O
that O
Sp1 B
binding I
site I
can O
function O
as O
a O
distinct O
TGF B
- I
beta I
responsive I
element I
for O
TGF B
- I
beta I
mediated O
promoter O
expression O
and O
Sp1 B
per O
se O
can O
mediate O
this O
response O
. O

Together O
with O
the O
up O
- O
regulation O
of O
the O
cAMP B
response I
element I
modulator I
protein I
( O
CREM B
) O
mRNA O
and O
protein O
levels O
demonstrated O
previously O
in O
CREB B
mutant I
mice O
, O
we O
suggest O
that O
the O
up O
- O
regulation O
of O
CREB B
beta I
may O
also O
contribute O
to O
compensation O
within O
the O
CREB B
/ O
ATF B
family O
of O
transcription O
factors O
, O
when O
CREB B
delta I
and O
CREB B
alpha I
are O
absent O
. O

The O
Grb2 B
SH3 B
( I
C I
) I
binding I
region I
of O
Gab1 B
has O
significant O
homology O
to O
a O
region O
of O
the O
adapter B
protein I
SLP I
- I
76 I
. O

The O
delayed O
activation O
of O
the O
prostaglandin B
G I
/ I
H I
synthase I
- I
2 I
promoter O
in O
bovine O
granulosa O
cells O
is O
associated O
with O
down O
- O
regulation O
of O
truncated O
upstream B
stimulatory I
factor I
- I
2 I
. O

New O
, O
selective O
catechol B
- I
O I
- I
methyltransferase I
inhibitors O
as O
therapeutic O
agents O
in O
Parkinson O
' O
s O
disease O
. O

We O
describe O
a O
novel O
stat B
- I
related I
factor I
, O
p93 B
, O
that O
is O
found O
in O
EGF B
- O
treated O
A431 O
cell O
extracts O
but O
appears O
to O
be O
absent O
in O
bovine B
fibroblast I
growth I
factor I
( O
bFGF B
) O
, O
IFN B
- I
gamma I
, O
tumor B
necrosis I
factor I
- I
alpha I
( O
TNF B
- I
alpha I
) O
, O
and O
untreated O
cells O
. O

Significantly O
, O
the O
murine B
P I
- I
selectin I
gene I
had O
several O
features O
not O
found O
in O
the O
human O
gene O
. O

In O
this O
group O
of O
patients O
, O
the O
mean O
LH B
( O
9 O
. O
3 O
+ O
/ O
- O
5 O
. O
9 O
IU O
/ O
l O
) O
and O
sex B
- I
hormone I
binding I
globulin I
( O
SHBG B
) O
( O
54 O
. O
5 O
+ O
/ O
- O
22 O
. O
9 O
nmol O
/ O
l O
) O
concentrations O
were O
significantly O
greater O
than O
those O
of O
five O
normal O
control O
subjects O
( O
4 O
. O
7 O
+ O
/ O
- O
1 O
. O
11 O
IU O
/ O
l O
and O
26 O
. O
0 O
+ O
/ O
- O
7 O
. O
0 O
nmol O
/ O
l O
respectively O
) O
. O

Both O
proteins O
share O
sequence O
similarity O
with O
the O
myelin B
- I
associated I
glycoprotein I
, O
an O
adhesion O
molecule O
of O
oligodendrocytes O
and O
Schwann O
cells O
that O
has O
been O
implicated O
in O
the O
process O
of O
myelination O
, O
raising O
the O
important O
question O
of O
whether O
myelin B
- I
associated I
glycoprotein I
is O
also O
a O
sialic B
acid I
- I
binding I
protein I
. O

Using O
the O
interaction O
- O
trap O
assay O
to O
identify O
candidate O
proteins O
that O
bind O
the O
cytoplasmic O
region O
of O
the O
LAR B
transmembrane I
protein I
tyrosine I
phosphatase I
( O
PT B
- I
Pase I
) O
, O
we O
isolated O
a O
cDNA O
encoding O
a O
2861 O
- O
amino O
acid O
protein O
termed O
Trio B
that O
contains O
three O
enzyme O
domains O
: O
two O
functional O
GEF B
domains I
and O
a O
protein B
serine I
/ I
threonine I
kinase I
( O
PSK B
) O
domain O
. O

Using O
the O
interaction O
- O
trap O
assay O
to O
identify O
candidate O
proteins O
that O
bind O
the O
cytoplasmic O
region O
of O
the O
LAR B
transmembrane I
protein I
tyrosine I
phosphatase I
( O
PT B
- I
Pase I
) O
, O
we O
isolated O
a O
cDNA O
encoding O
a O
2861 O
- O
amino O
acid O
protein O
termed O
Trio B
that O
contains O
three O
enzyme O
domains O
: O
two O
functional O
GEF B
domains I
and O
a O
protein B
serine I
/ I
threonine I
kinase I
( O
PSK B
) O
domain O
. O

Based O
on O
the O
results O
of O
this O
analysis O
, O
we O
also O
predict O
that O
the O
budding B
yeast I
arsenate I
resistance I
protein I
Acr2 B
and O
the O
ORF B
Ygr203w I
encode O
protein O
phosphatases O
with O
catalytic O
properties O
similar O
to O
that O
of O
the O
Cdc25 B
family I
. O

We O
suggest O
that O
the O
responses O
to O
types B
I I
and I
II I
collagen I
were O
caused O
by O
a O
cross O
- O
reaction O
with O
type B
III I
collagen I
peptides O
. O

Recombinant B
apoA I
- I
I I
protein I
recovered O
from O
the O
soluble O
fraction O
of O
the O
bacterial O
cell O
pellet O
was O
purified O
to O
greater O
than O
95 O
% O
homogeneity O
by O
reversed O
- O
phase O
high O
- O
performance O
liquid O
chromatography O
. O

Our O
results O
suggest O
that O
at O
least O
some O
chloroplast B
- I
like I
tRNA I
genes I
in O
wheat O
mtDNA O
are O
transcribed O
, O
with O
transcripts O
undergoing O
processing O
, O
post O
- O
transcriptional O
modification O
and O
3 O
' O
- O
CCA O
addition O
, O
to O
produce O
mature O
tRNAs O
that O
may O
participate O
in O
mitochondrial O
protein O
synthesis O
. O

Mutations O
in O
Saccharomyces O
cerevisiae O
that O
block O
meiotic O
prophase O
chromosome O
metabolism O
and O
confer O
cell O
cycle O
arrest O
at O
pachytene O
identify O
two O
new O
meiosis B
- I
specific I
genes I
SAE1 I
and O
SAE3 B
. O

Northern O
( O
RNA O
) O
blot O
hybridization O
analysis O
with O
the O
p68c B
- I
ets I
- I
1 I
- O
specific O
sequence O
and O
RNase B
protection O
experiments O
showed O
that O
the O
corresponding O
mRNA O
was O
expressed O
in O
normal O
chicken O
spleen O
and O
not O
in O
normal O
chicken O
thymus O
or O
in O
various O
T O
lymphoid O
cell O
lines O
. O

In O
contrast O
to O
p62 B
( O
dok B
) O
, O
DOKL B
lacks O
YxxP O
motifs O
in O
the O
C O
terminus O
and O
does O
not O
bind O
to O
Ras B
GTPase I
- I
activating I
protein I
( O
RasGAP B
) O
upon O
phosphorylation O
. O

The O
peptides O
are O
generated O
in O
the O
cytosol O
, O
then O
translocated O
across O
the O
membrane O
of O
the O
endoplasmic O
reticulum O
by O
the O
transporter B
associated I
with I
antigen I
processing I
( O
TAP B
) O
. O

K562 O
erythroleukemia O
cells O
stably O
transfected O
with O
constructs O
containing O
the O
human B
Agamma I
- I
globin I
promoter I
linked O
to O
an O
enhanced B
green I
fluorescent I
protein I
( O
EGFP B
) O
reporter O
, O
with O
or O
without O
HS2 O
, O
were O
analyzed O
for O
EGFP B
expression O
by O
flow O
cytometry O
. O

Here O
, O
we O
report O
the O
isolation O
of O
a O
new O
spindle O
checkpoint O
gene O
, O
mph1 B
( O
Mps1p B
- I
like I
pombe I
homolog I
) O
, O
in O
the O
fission O
yeast O
Schizosaccharomyces O
pombe O
, O
that O
is O
required O
for O
checkpoint O
activation O
in O
response O
to O
spindle O
defects O
. O

These O
transcripts O
directed O
the O
synthesis O
of O
three O
proteins O
: O
the O
virus B
trans I
- I
activator I
protein I
( O
EIAV B
Tat I
) O
encoded O
by O
ORF O
S1 O
, O
a O
protein O
of O
unknown O
function O
encoded O
by O
ORF O
S2 O
, O
and O
the O
virus O
envelope B
glycoprotein I
. O

Csk B
( O
C B
- I
terminal I
Src I
kinase I
) O
is O
a O
protein B
tyrosine I
kinase I
that O
phosphorylates O
Src B
family I
member I
C I
- I
terminal I
tails I
, O
resulting O
in O
downregulation O
of O
Src B
family O
members O
. O

Role O
of O
double B
- I
stranded I
RNA I
- I
dependent I
protein I
kinase I
in O
mediating O
hypersensitivity O
of O
Fanconi O
anemia O
complementation O
group O
C O
cells O
to O
interferon B
gamma I
, O
tumor B
necrosis I
factor I
- I
alpha I
, O
and O
double O
- O
stranded O
RNA O
. O

Human B
CD38 I
, O
a O
leukocyte O
receptor O
and O
ectoenzyme O
, O
is O
a O
member O
of O
a O
novel O
eukaryotic O
gene O
family O
of O
nicotinamide B
adenine I
dinucleotide I
+ I
- I
converting I
enzymes I
: O
extensive O
structural O
homology O
with O
the O
genes O
for O
murine B
bone I
marrow I
stromal I
cell I
antigen I
1 I
and O
aplysian B
ADP I
- I
ribosyl I
cyclase I
. O

The O
two O
yeast B
pheromone I
receptors I
, O
the O
a B
and I
alpha I
- I
factor I
receptors I
, O
share O
many O
functional O
similarities O
: O
both O
G B
protein I
- I
coupled I
receptors I
couple O
to O
the O
same O
downstream O
signal O
transduction O
pathway O
, O
and O
both O
receptors O
undergo O
feedback O
regulation O
involving O
increased O
phosphorylation O
on O
their O
C O
- O
terminal O
domains O
in O
response O
to O
ligand O
challenge O
. O

In O
contrast O
, O
an O
N B
- I
terminal I
RNAP I
mutant I
that O
has O
a O
decreased O
capacity O
to O
bind O
single O
- O
stranded O
RNA O
forms O
halted O
complexes O
with O
much O
lower O
levels O
of O
stability O
than O
the O
WT O
enzyme O
, O
and O
these O
complexes O
are O
not O
stabilized O
by O
the O
presence O
of O
the O
NT O
strand O
. O

To O
elucidate O
the O
molecular O
mechanism O
by O
which O
the O
Ras B
signaling O
pathway O
activates O
a O
cell O
- O
type O
- O
specific O
gene O
, O
we O
have O
used O
the O
pituitary B
- I
specific I
rat I
prolactin I
( O
rPRL B
) O
promoter O
as O
a O
target O
of O
oncogenic B
Ras I
and O
Raf B
in O
GH4 O
rat O
pituitary O
cells O
. O

The O
1 O
. O
6 O
- O
kb O
cDNA O
( O
CBF B
- I
A I
) O
encoding O
285 O
amino O
acids O
( O
aa O
) O
was O
obtained O
, O
and O
a O
beta B
- I
galactosidase I
fusion I
protein I
, O
bacterially O
produced O
from O
the O
cDNA O
, O
bound O
to O
DNA O
fragments O
containing O
several O
CArG O
boxes O
. O

Comparison O
of O
the O
footprint O
patterns O
of O
the O
mouse B
and I
human I
HPRT I
genes I
demonstrated O
that O
the O
in O
vivo O
binding O
of O
regulatory O
proteins O
between O
these O
species O
is O
generally O
conserved O
but O
not O
identical O
. O

In O
this O
report O
, O
we O
demonstrate O
that O
FRS2 B
forms O
a O
complex O
with O
the O
N B
- I
terminal I
SH2 I
domain I
of O
the O
protein B
tyrosine I
phosphatase I
Shp2 I
in O
response O
to O
FGF B
stimulation O
. O

These O
results O
establish O
that O
the O
DNA O
fragment O
we O
have O
isolated O
contains O
the O
human B
gp130 I
promoter I
and O
that O
interleukin B
- I
6 I
type I
cytokines I
may O
influence O
the O
activity O
of O
this O
promoter O
via O
activated O
STATs B
. O

When O
targeted O
to O
the O
GAL1 B
promoter I
by O
fusing O
with O
the O
Gal4p B
DNA I
- I
binding I
domain I
, O
Sko1p B
acts O
as O
an O
Ssn6 B
/ O
Tup1p B
- O
dependent O
repressor O
regulated O
by O
osmotic O
stress O
. O

Growth O
factors O
promote O
cell O
survival O
through O
phosphorylation O
of O
Bad B
, O
resulting O
in O
its O
dissociation O
from O
Bcl B
- I
2 I
and O
Bcl B
- I
x I
( I
L I
) I
and O
its O
association O
with O
14 B
- I
3 I
- I
3tau I
. O

The O
herpesvirus B
entry I
mediator I
C I
( O
HveC B
) O
, O
previously O
known O
as O
poliovirus B
receptor I
- I
related I
protein I
1 I
( O
PRR1 B
) O
, O
and O
the O
herpesvirus B
Ig I
- I
like I
receptor I
( O
HIgR B
) O
are O
the O
bona O
fide O
receptors O
employed O
by O
herpes O
simplex O
virus O
- O
1 O
and O
- O
2 O
( O
HSV O
- O
1 O
and O
- O
2 O
) O
for O
entry O
into O
the O
human O
cell O
lines O
most O
frequently O
used O
in O
HSV O
studies O
. O

This O
integration O
results O
in O
the O
production O
of O
MMTV B
/ I
mdr3 I
fusion I
transcripts I
that O
originate O
from O
the O
antisense O
5 B
' I
LTR I
of O
the O
provirus O
. O

Transcriptional O
analysis O
indicates O
that O
human B
TBP I
functions O
poorly O
at O
promoters O
recognized O
by O
RNA B
polymerases I
I I
and I
III I
and O
at O
RNA B
Pol I
II I
promoters I
lacking O
a O
conventional O
TATA O
element O
. O

Electrophoretic O
mobility O
shift O
assays O
demonstrated O
that O
sequences O
within O
this O
region O
bind O
members O
of O
the O
Sp1 B
family I
of I
transcription I
factors I
. O

Heterotrimeric O
guanine B
nucleotide I
- I
binding I
proteins I
( O
G B
- I
proteins I
) O
function O
as O
signal O
transducers O
for O
a O
variety O
of O
hormone O
- O
coupled O
enzyme O
and O
ion O
transport O
systems O
in O
eukaryotic O
cells O
. O

Small B
t I
also O
inhibited O
the O
dephosphorylation O
of O
cAMP B
- I
dependent I
protein I
kinase I
( O
PKA B
) O
- O
phosphorylated O
CREB B
in O
rat O
liver O
nuclear O
extracts O
. O

Presently O
, O
we O
made O
chain O
pair O
switch O
, O
chimeric O
, O
and O
site O
mutant B
gamma I
delta I
TCRs I
and O
transfected O
them O
into O
TCR O
- O
mutant O
Jurkat O
T O
cells O
to O
examine O
the O
effects O
of O
changing O
the O
TCR B
gamma I
junctional I
region I
sequences I
on O
reactivity O
to O
prenyl B
pyrophosphate I
Ags I
. O

The O
present O
report O
shows O
that O
a O
cis O
- O
acting O
element O
between O
- O
189 O
and O
- O
175 O
bp O
, O
which O
binds O
thyroid B
transcription I
factor I
- I
1 I
( O
TTF B
- I
1 I
) O
, O
is O
involved O
in O
both O
activities O
. O

Increased O
platelet B
- I
derived I
growth I
factor I
production O
and O
intimal O
thickening O
during O
healing O
of O
Dacron O
grafts O
in O
a O
canine O
model O
. O

It O
also O
produces O
an O
NH2 O
terminus O
that O
corresponds O
to O
an O
equivalent O
NH2 O
terminus O
on O
the O
processed O
matrix O
form O
of O
the O
similar O
alpha1 B
( I
XI I
) I
chain I
, O
thus O
suggesting O
physiological O
significance O
. O

DESIGN O
: O
Activating B
protein I
- I
1 I
( O
AP B
- I
1 I
) O
and O
Tat B
- O
induced O
transcription O
were O
assessed O
using O
Jun B
and O
hybrid O
Tat B
/ O
Jun B
- O
expression O
plasmids O
and O
reporter O
gene O
constructs O
which O
contained O
AP B
- I
1 I
binding I
sites I
upstream O
of O
the O
rat B
prolactin I
TATAA I
element I
or O
an O
HIV B
- I
1 I
LTR I
construct I
in O
which O
AP B
- I
1 I
binding I
sites I
replaced O
the O
TAR O
element O
. O

DESIGN O
: O
Activating B
protein I
- I
1 I
( O
AP B
- I
1 I
) O
and O
Tat B
- O
induced O
transcription O
were O
assessed O
using O
Jun B
and O
hybrid O
Tat B
/ O
Jun B
- O
expression O
plasmids O
and O
reporter O
gene O
constructs O
which O
contained O
AP B
- I
1 I
binding I
sites I
upstream O
of O
the O
rat B
prolactin I
TATAA I
element I
or O
an O
HIV B
- I
1 I
LTR I
construct I
in O
which O
AP B
- I
1 I
binding I
sites I
replaced O
the O
TAR O
element O
. O

DESIGN O
: O
Activating B
protein I
- I
1 I
( O
AP B
- I
1 I
) O
and O
Tat B
- O
induced O
transcription O
were O
assessed O
using O
Jun B
and O
hybrid O
Tat B
/ O
Jun B
- O
expression O
plasmids O
and O
reporter O
gene O
constructs O
which O
contained O
AP B
- I
1 I
binding I
sites I
upstream O
of O
the O
rat B
prolactin I
TATAA I
element I
or O
an O
HIV B
- I
1 I
LTR I
construct I
in O
which O
AP B
- I
1 I
binding I
sites I
replaced O
the O
TAR O
element O
. O

Signaling O
through O
mitogen B
- I
activated I
protein I
kinase I
and O
Rac B
/ O
Rho B
does O
not O
duplicate O
the O
effects O
of O
activated O
Ras B
on O
skeletal O
myogenesis O
. O

The O
region O
surrounding O
the O
ZNF35 B
zinc I
finger I
protein I
gene I
on O
3p21 O
is O
of O
particular O
interest O
, O
as O
this O
region O
of O
chromosome O
3 O
is O
frequently O
involved O
in O
rearrangements O
and O
/ O
or O
deletions O
associated O
with O
various O
human O
tumors O
including O
lung O
and O
renal O
carcinoma O
. O

Western O
blot O
analyses O
reveals O
that O
cJun B
and O
the O
C B
/ I
EBP I
family I
member I
C B
/ I
EBP I
- I
beta I
are O
physiologically O
relevant O
transcription O
factors O
whose O
expression O
corresponds O
with O
mda B
- I
7 I
mRNA I
expression O
. O

Western O
blot O
analyses O
reveals O
that O
cJun B
and O
the O
C B
/ I
EBP I
family I
member I
C B
/ I
EBP I
- I
beta I
are O
physiologically O
relevant O
transcription O
factors O
whose O
expression O
corresponds O
with O
mda B
- I
7 I
mRNA I
expression O
. O

Minute B
virus I
of I
mice I
NS1 I
, O
an O
83 O
- O
kDa O
mainly O
nuclear O
phosphoprotein O
, O
is O
the O
only O
viral O
nonstructural O
protein O
required O
in O
all O
cell O
types O
and O
it O
is O
involved O
in O
multiple O
processes O
necessary O
for O
virus O
propagation O
. O

Since O
RIP140 B
generally O
down O
- O
regulates O
receptor O
activity O
in O
mammalian O
cells O
and O
specifically O
down O
- O
regulates O
coactivation O
mediated O
by O
SRC B
- I
1 I
, O
we O
propose O
a O
model O
in O
which O
RIP140 B
indirectly O
regulates O
nuclear B
receptor I
AF I
- I
2 I
activity O
by O
competition O
for O
coactivators O
such O
as O
SRC B
- I
1 I
. O

In O
cells O
stably O
transfected O
with O
G B
alpha I
i I
- I
2 I
or O
G B
alpha I
i I
- I
3 I
gene I
5 O
' O
- O
flanking O
sequences O
fused O
to O
firefly O
luciferase B
cDNA O
reporter O
, O
temporal O
10 O
- O
15 O
- O
fold O
transcriptional O
activation O
of O
both O
genes O
occurred O
before O
cellular O
polarization O
. O

Database O
searches O
revealed O
a O
50 O
- O
63 O
% O
similarity O
and O
34 O
- O
42 O
% O
identity O
with O
several O
families O
of O
serine B
proteases I
, O
in O
particular O
the O
trypsin B
- I
like I
proteases I
, O
members O
of O
the O
glandular B
kallikrein I
family I
( O
including O
prostate B
- I
specific I
antigen I
, O
nerve B
growth I
factor I
gamma I
, O
and O
epidermal B
growth I
factor I
- I
binding I
protein I
) O
and O
the O
activators O
for O
the O
kringle B
family I
proteins I
( O
including O
the O
human B
tissue I
plasminogen I
activator I
and O
human B
hepatocyte I
growth I
factor I
activator I
) O
. O

We O
established O
that O
, O
in O
unstimulated O
lymphocytes O
, O
the O
Src B
homology I
2 I
( O
SH2 B
) O
and O
SH3 B
domain I
- I
containing I
protein I
Grb2 B
and O
the O
p85 B
subunit O
of O
phosphatidylinositol B
3 I
- I
kinase I
, O
associate O
constitutively O
with O
Cbl B
via O
their O
SH3 B
domains I
. O

In O
contrast O
, O
inactivation O
of O
the O
Sir4p B
- I
interacting I
protein I
Rap1p I
reduces O
partitioning O
by O
a O
LexA B
- O
Sir4p B
fusion O
. O

Characterization O
of O
human B
activating I
transcription I
factor I
4 I
, O
a O
transcriptional O
activator O
that O
interacts O
with O
multiple O
domains O
of O
cAMP B
- I
responsive I
element I
- I
binding I
protein I
( O
CREB B
) O
- O
binding O
protein O
. O

In O
contrast O
to O
the O
reciprocal O
effects O
of O
Gab1 B
and O
Gab2 B
in O
mediating O
Elk B
- I
1 I
induction O
, O
these O
two O
molecules O
have O
a O
similar O
function O
in O
extracellular B
signal I
- I
regulated I
kinase I
activation O
induced O
by O
either O
oncogenic O
Ras B
or O
growth O
factor O
stimulation O
. O

The O
testes O
of O
8 O
specimens O
of O
Triturus O
marmoratus O
were O
collected O
during O
each O
month O
of O
1987 O
and O
processed O
for O
electron O
microscopy O
and O
light O
microscopy O
demonstration O
of O
testosterone O
( O
T O
) O
following O
the O
ABC B
( O
avidin B
- I
biotin I
peroxidase I
complex I
) O
method O
. O

The O
non B
- I
major I
histocompatibility I
complex I
( O
MHC B
) O
- O
encoded O
CD1 B
family I
has O
recently O
emerged O
as O
a O
new O
antigen O
- O
presenting O
system O
that O
is O
distinct O
from O
either O
MHC B
class I
I I
or I
class I
II I
molecules I
. O

These O
events O
were O
only O
weakly O
stimulated O
by O
the O
activated B
PDGF I
alpha I
- I
receptor I
. O

Footprints O
on O
the O
HPV B
18 I
enhancer I
show O
five O
protected O
regions O
with O
homologies O
to O
NF1 B
, O
AP1 B
and O
EFII B
transcription I
factor I
binding I
motifs I
. O

Here O
we O
show O
that O
the O
nucleotide O
in O
the O
middle O
of O
the O
anticodon O
( O
i O
. O
e O
. O
, O
psi O
35 O
) O
also O
contributes O
to O
the O
suppressor O
efficiency O
displayed O
by O
cytoplasmic B
tRNA I
( I
Tyr I
) I
. O

Role O
of O
zinc B
- I
finger I
proteins I
Sp1 I
and O
zif268 B
/ O
egr B
- I
1 I
in O
transcriptional O
regulation O
of O
the O
human B
synaptobrevin I
II I
gene I
. O

The O
human B
Fc I
gamma I
receptor I
gene I
Fc B
gamma I
RIIA I
is O
expressed O
in O
platelets O
, O
neutrophils O
, O
monocytes O
and O
macrophages O
. O

These O
results O
demonstrate O
the O
extensive O
homology O
in O
sequence O
among O
light O
chains O
of O
IgM B
kappa I
autoantibodies I
and O
indicate O
that O
a O
particular O
V B
kappa I
germ I
line I
gene I
, O
kappa B
IIIb I
, O
is O
expressed O
as O
a O
phylogenetic O
response O
to O
certain O
self O
antigens O
or O
as O
part O
of O
a O
selection O
process O
by O
which O
these O
autoimmune O
responses O
are O
regulated O
. O

Comparison O
of O
the O
sequences O
of O
the O
alpha B
- I
like I
DNA I
polymerases I
including O
E B
. I
coli I
DNA I
polymerase I
II I
showed O
that O
there O
were O
nine O
highly O
conserved O
regions O
, O
and O
we O
constructed O
an O
unrooted O
phylogenetic O
tree O
of O
the O
DNA B
polymerases I
based O
on O
the O
differences O
in O
these O
conserved O
regions O
. O

trans O
- O
activation O
of O
the O
HIV B
- I
1 I
LTR I
by O
the O
HIV B
- I
1 I
Tat I
and O
HTLV B
- I
I I
Tax I
proteins I
is O
mediated O
by O
different O
cis O
- O
acting O
sequences O
. O

VLA B
- I
4 I
integrin I
cross O
- O
linking O
on O
human O
monocytic O
THP O
- O
1 O
cells O
induces O
tissue O
factor O
expression O
by O
a O
mechanism O
involving O
mitogen B
- I
activated I
protein I
kinase I
. O

Finally O
, O
we O
demonstrated O
that O
although O
the O
DNA O
- O
binding O
domain O
of O
c B
- I
myb I
is O
required O
for O
both O
the O
differentiation O
block O
and O
the O
shift O
in O
cell O
cycle O
after O
PMA O
treatment O
, O
phosphorylation O
by O
casein B
kinase I
II I
and O
mitogen B
- I
activated I
protein I
kinase I
at O
positions O
11 O
and O
12 O
or O
532 O
of O
c B
- I
myb I
, O
respectively O
, O
are O
not O
. O

The O
myeloid B
zinc I
finger I
gene I
1 I
( O
MZF1 B
) O
encodes O
a O
C B
( I
2 I
) I
H I
( I
2 I
) I
zinc I
finger I
transcription I
factor I
that O
regulates O
granulopoiesis O
and O
may O
have O
a O
regulatory O
role O
in O
cellular O
proliferation O
and O
oncogenesis O
. O

cDNA O
cloning O
and O
transcriptional O
properties O
of O
a O
novel O
GC B
box I
- I
binding I
protein I
, O
BTEB2 B
. O

Replacement O
of O
Val20 O
- O
Leu21 O
with O
Ala O
- O
Ala O
produced O
a O
dimeric B
RII I
beta I
protein I
that O
binds O
AKAP75 B
approximately O
4 O
% O
as O
avidly O
as O
wild B
- I
type I
RII I
beta I
. O

Replacement O
of O
a O
valine O
( O
V68 O
) O
in O
the O
ETS B
domain O
of O
SAP1a B
by O
aspartic O
acid O
( O
as O
found O
in O
c B
- I
Ets I
- I
1 I
, O
Elk B
- I
1 I
, O
and O
Net B
) O
enhanced O
ternary O
complex O
formation O
by O
more O
than O
60 O
- O
fold O
. O

The O
atf1 B
+ I
gene I
of I
Schizosaccharomyces I
pombe I
encodes O
a O
bZIP B
transcription I
factor I
with O
strong O
homology O
to O
the O
mammalian B
factor I
ATF I
- I
2 I
. O

Regulation O
of O
activating B
transcription I
factor I
- I
1 I
and O
the O
cAMP B
response I
element I
- I
binding I
protein I
by O
Ca2 B
+ I
/ I
calmodulin I
- I
dependent I
protein I
kinases I
type I
I I
, I
II I
, I
and I
IV I
. O

Furthermore O
, O
we O
demonstrate O
that O
in O
myeloid O
and O
B O
cell O
extracts O
, O
PU B
. I
1 I
forms O
a O
novel O
, O
specific O
, O
more O
slowly O
migrating O
complex O
( O
PU B
- I
SF I
) O
when O
binding O
the O
GM B
- I
CSF I
receptor I
alpha I
promoter O
PU B
. I
1 I
site O
. O

G B
- I
box I
binding I
factors I
( O
GBFs B
) O
constitute O
a O
family O
of O
plant O
DNA O
- O
binding O
proteins O
that O
bind O
to O
the O
G O
- O
box O
motif O
, O
a O
regulatory O
cis O
element O
present O
in O
many O
plant O
genes O
with O
a O
palindromic O
DNA O
motif O
of O
CACGTG O
. O

These O
results O
extend O
our O
knowledge O
of O
this O
SNF2 B
- I
like I
family I
member I
and O
suggest O
a O
role O
for O
PASG B
in O
leukemogenesis O
. O

Transient O
transfection O
assays O
indicated O
that O
the O
( O
- O
4551 O
) O
UCP1 B
- O
CAT B
construct O
, O
containing O
the O
5 O
' O
- O
regulatory O
region O
of O
the O
rat B
ucp I
- I
1 I
gene I
, O
was O
activated O
by O
PPARalpha B
co O
- O
transfection O
in O
a O
dose O
- O
dependent O
manner O
and O
this O
activation O
was O
potentiated O
by O
Wy O
14 O
, O
643 O
and O
retinoid B
X I
receptor I
alpha I
. O

MsEPV O
genes O
with O
putative O
functions O
in O
prevention O
and O
repair O
of O
DNA O
damage O
include O
a O
complete O
base O
excision O
repair O
pathway O
( O
uracil B
DNA I
glycosylase I
, O
AP B
endonuclease I
, O
DNA B
polymerase I
beta I
, O
and O
an O
NAD B
+ I
- I
dependent I
DNA I
ligase I
) O
, O
a O
photoreactivation O
repair O
pathway O
( O
cyclobutane B
pyrimidine I
dimer I
photolyase I
) O
, O
a O
LINE B
- I
type I
reverse I
transcriptase I
, O
and O
a O
mutT B
homologue I
. O

The O
classic O
sterol O
regulatory O
cis O
element O
( O
sre O
- O
1 O
) O
in O
the O
LDL B
receptor I
promoter O
mediates O
sterol B
regulatory I
element I
binding I
protein I
( O
SREBP B
) O
- O
binding O
and O
the O
effects O
of O
insulin B
and O
platelet B
derived I
growth I
factor I
( O
PDGF B
) O
. O

Nb2 O
- O
11C O
cells O
expressed O
three O
PNR B
- I
related I
mRNA I
transcripts I
of O
2 O
. O
5 O
, O
3 O
. O
0 O
and O
> O
10 O
kb O
. O

The O
cloning O
of O
human B
apo I
B I
- I
100 I
has O
provided O
new O
insights O
into O
the O
structure O
and O
physicochemical O
properties O
of O
apo B
B I
- I
100 I
and O
will O
facilitate O
studies O
on O
the O
factors O
modulating O
apo B
B I
- I
100 I
biosynthesis O
and O
the O
expression O
of O
the O
apo B
B I
- I
100 I
gene I
in O
patients O
with O
dyslipoproteinemias O
. O

The O
cloning O
of O
human B
apo I
B I
- I
100 I
has O
provided O
new O
insights O
into O
the O
structure O
and O
physicochemical O
properties O
of O
apo B
B I
- I
100 I
and O
will O
facilitate O
studies O
on O
the O
factors O
modulating O
apo B
B I
- I
100 I
biosynthesis O
and O
the O
expression O
of O
the O
apo B
B I
- I
100 I
gene I
in O
patients O
with O
dyslipoproteinemias O
. O

The O
proteins O
encoded O
by O
these O
genes O
, O
called O
GF14 B
proteins I
, O
participate O
in O
protein O
/ O
DNA O
complexes O
and O
show O
more O
than O
60 O
% O
identity O
with O
a O
highly O
conserved O
, O
widely O
distributed O
protein O
family O
, O
collectively O
referred O
to O
as O
14 B
- I
3 I
- I
3 I
proteins O
. O

The O
predicted O
amino O
acid O
sequence O
contained O
all O
consensus O
regions O
for O
S B
- I
adenosyl I
methionine I
methyltransferases I
and O
presented O
26 O
% O
identity O
with O
Saccharomyces B
cerevisiae I
DHHB I
- I
methyltransferase I
and O
38 O
% O
identity O
with O
the O
rat O
protein O
, O
as O
well O
as O
with O
a O
bacterial O
( O
Escherichia O
coli O
and O
Salmonella O
typhimurium O
) O
methyltransferase B
encoded O
by O
the O
UBIG B
gene I
. O

The O
predicted O
amino O
acid O
sequence O
contained O
all O
consensus O
regions O
for O
S B
- I
adenosyl I
methionine I
methyltransferases I
and O
presented O
26 O
% O
identity O
with O
Saccharomyces B
cerevisiae I
DHHB I
- I
methyltransferase I
and O
38 O
% O
identity O
with O
the O
rat O
protein O
, O
as O
well O
as O
with O
a O
bacterial O
( O
Escherichia O
coli O
and O
Salmonella O
typhimurium O
) O
methyltransferase B
encoded O
by O
the O
UBIG B
gene I
. O

The O
expression O
of O
the O
leukocyte B
EL I
- I
246 I
antigen I
was O
regulated O
in O
the O
same O
manner O
as O
L B
- I
selectin I
and O
EL B
- I
246 I
recognized O
anti B
- I
L I
- I
selectin I
mAb I
affinity O
- O
purified O
antigen O
in O
SDS O
/ O
PAGE O
Western O
blot O
analysis O
. O

The O
phosphatidylglycerol B
/ I
phosphatidylinositol I
transfer I
protein I
( O
PG B
/ I
PI I
- I
TP I
) O
is O
a O
new O
and O
original O
phospholipid B
transfer I
protein I
( O
PLTP B
) O
isolated O
from O
the O
Deuteromycete O
, O
Aspergillus O
oryzae O
. O

The O
phosphatidylglycerol B
/ I
phosphatidylinositol I
transfer I
protein I
( O
PG B
/ I
PI I
- I
TP I
) O
is O
a O
new O
and O
original O
phospholipid B
transfer I
protein I
( O
PLTP B
) O
isolated O
from O
the O
Deuteromycete O
, O
Aspergillus O
oryzae O
. O

The O
level O
of O
expression O
of O
the O
PDE B
protein I
was O
monitored O
by O
immunoblot O
analysis O
using O
two O
specific O
cAMP B
- I
PDE I
polyclonal I
antibodies I
and O
by O
measuring O
the O
PDE B
activity O
. O

These O
studies O
reveal O
that O
CREM B
, O
a O
tissue O
- O
specific O
factor O
, O
is O
expressed O
and O
regulated O
by O
gonadotropins B
in O
the O
ovary O
, O
that O
the O
predominant O
CREM B
transcripts O
encode O
the O
repressor B
protein I
ICER I
, O
and O
that O
ICER B
is O
capable O
of O
inhibiting O
cAMP O
- O
induced O
expression O
of O
the O
inhibin B
alpha I
- I
subunit I
gene I
. O

The O
Brassica B
BTH1 I
gene I
may O
correspond O
to O
the O
Arabidopsis B
TH I
- I
1 I
gene I
. O

The O
mitochondrial B
tyrosyl I
- I
tRNA I
synthetase I
of O
Podospora O
anserina O
is O
a O
bifunctional O
enzyme O
active O
in O
protein O
synthesis O
and O
RNA O
splicing O
. O

We O
found O
both O
the O
v B
- I
Ras I
- O
and O
PC B
- I
PLC I
- O
transformed O
cells O
to O
be O
insensitive O
to O
stimulation O
with O
platelet B
- I
derived I
growth I
factor I
( O
PDGF B
) O
. O

TRAF2 B
has O
previously O
been O
demonstrated O
to O
activate O
both O
transcription O
factor O
nuclear B
factor I
kappaB I
( O
NFkappaB B
) O
and O
the O
c B
- I
Jun I
N I
- I
terminal I
kinase I
/ O
stress B
- I
activated I
protein I
kinase I
( O
JNK B
/ O
SAPK B
) O
pathway O
, O
which O
in O
turn O
stimulates O
transcription B
factor I
activating I
protein I
1 I
( O
AP1 B
) O
mainly O
via O
phosphorylation O
of O
the O
c B
- I
Jun I
component O
. O

TRAF2 B
has O
previously O
been O
demonstrated O
to O
activate O
both O
transcription O
factor O
nuclear B
factor I
kappaB I
( O
NFkappaB B
) O
and O
the O
c B
- I
Jun I
N I
- I
terminal I
kinase I
/ O
stress B
- I
activated I
protein I
kinase I
( O
JNK B
/ O
SAPK B
) O
pathway O
, O
which O
in O
turn O
stimulates O
transcription B
factor I
activating I
protein I
1 I
( O
AP1 B
) O
mainly O
via O
phosphorylation O
of O
the O
c B
- I
Jun I
component O
. O

Despite O
this O
dependency O
, O
however O
, O
a O
B B
. I
japonicum I
fixK I
mutant I
did O
not O
have O
the O
phenotypic O
characteristics O
of O
B B
. I
japonicum I
fixL I
and O
fixJ B
mutants I
: O
the O
fixK B
mutant I
was O
neither O
Fix O
- O
in O
symbiosis O
with O
soybean O
plants O
nor O
defective O
in O
anaerobic O
respiration O
with O
nitrate O
as O
the O
terminal O
electron O
acceptor O
. O

Northern O
blot O
analysis O
of O
enoyl B
- I
ACP I
reductase I
mRNA I
steady O
- O
state O
levels O
during O
seed O
development O
suggests O
that O
the O
increase O
in O
enzyme O
activity O
during O
the O
phase O
of O
storage O
lipid O
accumulation O
is O
regulated O
at O
the O
level O
of O
gene O
expression O
. O

It O
has O
also O
been O
previously O
demonstrated O
that O
LPS O
treatment O
of O
splenic O
B O
cells O
from O
athymic O
mice O
results O
in O
a O
decrease O
in O
steady O
state O
mRNA O
encoding O
the O
A B
alpha I
class I
II I
protein I
. O

Mutational O
analysis O
of O
the O
putative O
effector O
domain O
of O
the O
GTP B
- I
binding I
Ypt1 I
protein I
in O
yeast O
suggests O
specific O
regulation O
by O
a O
novel O
GAP B
activity O
. O

Instead O
, O
HBx B
is O
shown O
to O
activate O
the O
cyclin B
A I
promoter I
, O
induce O
cyclin B
A I
- O
cyclin B
- I
dependent I
kinase I
2 I
complexes O
, O
and O
promote O
cycling O
of O
growth O
- O
arrested O
cells O
into O
G1 O
through O
a O
pathway O
involving O
activation O
of O
Src B
tyrosine I
kinases I
. O

The O
organelles O
synthesize O
their O
own O
set O
of O
Fe B
/ I
S I
proteins I
, O
and O
they O
initiate O
the O
generation O
of O
extramitochondrial B
Fe I
/ I
S I
proteins I
. O

A O
genomic O
clone O
of O
the O
chicken B
osteopontin I
- I
encoding I
gene I
( O
opn B
) O
was O
isolated O
and O
found O
to O
be O
organized O
as O
follows O
: O
an O
untranslated O
5 O
' O
exon O
; O
a O
signal O
peptide O
; O
a O
recognition O
sequence O
for O
phosphorylation O
by O
casein B
kinase I
II I
; O
a O
domain O
containing O
a O
possible O
O O
- O
linkage O
site O
for O
glycosylation O
; O
a O
second O
casein B
kinase I
II I
phosphorylation I
site I
; O
an O
exon O
containing O
three O
functional O
regions O
, O
the O
poly O
- O
Asp O
sequence O
of O
seven O
consecutive O
Asp O
residues O
, O
the O
RGD B
integrin I
recognition I
site I
and O
a O
potential O
N O

A O
genomic O
clone O
of O
the O
chicken B
osteopontin I
- I
encoding I
gene I
( O
opn B
) O
was O
isolated O
and O
found O
to O
be O
organized O
as O
follows O
: O
an O
untranslated O
5 O
' O
exon O
; O
a O
signal O
peptide O
; O
a O
recognition O
sequence O
for O
phosphorylation O
by O
casein B
kinase I
II I
; O
a O
domain O
containing O
a O
possible O
O O
- O
linkage O
site O
for O
glycosylation O
; O
a O
second O
casein B
kinase I
II I
phosphorylation I
site I
; O
an O
exon O
containing O
three O
functional O
regions O
, O
the O
poly O
- O
Asp O
sequence O
of O
seven O
consecutive O
Asp O
residues O
, O
the O
RGD B
integrin I
recognition I
site I
and O
a O
potential O
N O

The O
vaccinia O
virus O
D6R B
open O
reading O
frame O
encodes O
the O
small O
subunit O
of O
the O
heterodimeric O
vaccinia B
virus I
early I
transcription I
factor I
( O
VETF B
) O
that O
activates O
transcription O
of O
early B
genes I
in O
vitro O
. O

The O
data O
also O
suggest O
that O
gamma B
CACCC I
box I
binding I
factors I
mediate O
LCR B
- I
gamma I
interactions O
which O
normally O
enhance O
gamma B
- I
globin I
and O
suppress O
beta B
- I
globin I
gene I
expression O
in O
fetal O
erythroid O
cells O
. O

The O
major O
promoter O
element O
of O
the O
Xenopus B
laevis I
5S I
RNA I
gene I
is O
located O
within O
the O
transcribed O
region O
of O
the O
gene O
and O
forms O
the O
binding O
site O
for O
the O
transcription O
initiation O
factor O
TFIIIA B
. O

The O
gamma B
- I
GCS I
gene I
is O
expressed O
ubiquitously O
and O
induced O
coordinately O
with O
NAD B
( I
P I
) I
H I
: I
quinone I
oxidoreductase I
( I
1 I
) I
( O
NQO1 B
) O
and O
glutathione B
S I
- I
transferase I
Ya I
( O
GST B
Ya I
) O
in O
response O
to O
xenobiotics O
and O
antioxidants O
. O

Activation O
of O
tyrosine B
kinase I
- I
containing I
receptors I
, O
heterotrimeric B
G I
proteins I
, O
and O
protein B
kinase I
C I
enhanced O
the O
activities O
of O
both O
MEK B
isoforms I
in O
293 O
and O
PC12 O
cells O
. O

The O
1031 B
- I
bp I
wild I
- I
type I
HIT1 I
DNA I
which O
contained O
an O
open O
reading O
frame O
encoding O
a O
protein O
of O
164 O
amino O
acids O
and O
the O
AGG B
arginine I
tRNA I
gene I
complemented O
all O
hit1 B
- I
1 I
mutant I
phenotypes I
, O
indicating O
that O
the O
mutant O
phenotypes O
were O
caused O
by O
the O
deletion O
of O
these O
genes O
. O

The O
gene O
encoding O
the O
Neisseria B
lactamica I
III I
DNA I
methyltransferase I
( O
M B
. I
NlaIII I
) O
which O
recognizes O
the O
sequence O
CATG O
has O
been O
cloned O
and O
expressed O
in O
Escherichia O
coli O
. O

Alignment O
of O
the O
rat B
and I
human I
WIN I
cDNAs I
and O
their O
comparison O
with O
mouse O
genomic O
sequence O
revealed O
that O
the O
WIN B
DNA I
binding I
domain I
is O
encoded O
by O
four O
exons O
, O
two O
of O
which O
( O
exons O
4 O
and O
6 O
) O
are O
alternatively O
spliced O
to O
generate O
at O
least O
three O
classes O
of O
mRNA O
transcripts O
. O

The O
immediate O
5 O
' O
- O
flanking O
region O
was O
GC O
- O
rich O
with O
3 O
SP B
- I
1 I
- I
like I
and O
2 O
AP B
- I
2 I
sites I
identified O
in O
close O
proximity O
to O
the O
transcription O
start O
site O
. O

Identification O
of O
domains O
mediating O
transcription O
activation O
, O
repression O
, O
and O
inhibition O
in O
the O
paired B
- I
related I
homeobox I
protein I
, O
Prx2 B
( O
S8 B
) O
. O

Sequences O
homologous O
to O
the O
consensus O
TUF B
- I
binding I
UAS I
boxes I
are O
present O
in O
the O
5 O
' O
flanking O
regions O
of O
both O
genes O
. O

The O
orthologs O
of O
the O
Y B
( I
1 I
) I
and O
Y B
( I
2 I
) I
subtypes I
display O
high O
amino O
acid O
sequence O
identities O
between O
pig O
, O
human O
, O
and O
mouse O
( O
92 O
% O
- O
94 O
% O
) O
, O
whereas O
the O
Y B
( I
4 I
) I
, O
Y B
( I
5 I
) I
, O
and O
y B
( I
6 I
) I
subtypes I
display O
lower O
identities O
( O
76 O
% O
- O
87 O
% O
) O
. O

The O
orthologs O
of O
the O
Y B
( I
1 I
) I
and O
Y B
( I
2 I
) I
subtypes I
display O
high O
amino O
acid O
sequence O
identities O
between O
pig O
, O
human O
, O
and O
mouse O
( O
92 O
% O
- O
94 O
% O
) O
, O
whereas O
the O
Y B
( I
4 I
) I
, O
Y B
( I
5 I
) I
, O
and O
y B
( I
6 I
) I
subtypes I
display O
lower O
identities O
( O
76 O
% O
- O
87 O
% O
) O
. O

A O
gene O
with O
a O
high O
degree O
of O
sequence O
identity O
with O
mammalian B
ADP I
- I
ribosylation I
factors I
( O
ARFs B
) O
, O
believed O
to O
be O
important O
in O
vesicular O
transport O
, O
was O
identified O
. O

The O
sections O
were O
stained O
with O
anti O
- O
polymorphonuclear O
leukocyte O
antibody O
, O
the O
endothelial O
marker O
factor B
VIII I
- I
related I
antigen I
, O
and O
with O
hematoxylin O
and O
eosin O
. O

The O
specificity O
of O
the O
transcriptional O
activation O
by O
ISGF3 B
is O
mediated O
by O
specific O
elements O
termed O
IFN B
- I
stimulatory I
response I
element I
( O
ISRE B
) O
located O
in O
the O
promoter O
region O
of O
IFN B
- O
inducible O
genes O
. O

Spinophilin B
, O
a O
novel O
protein B
phosphatase I
1 I
binding I
protein I
localized O
to O
dendritic O
spines O
. O

We O
have O
found O
that O
pro B
- I
IGF I
- I
2 I
can O
initially O
form O
two O
disulfide O
isomers O
that O
undergo O
rearrangement O
to O
a O
single O
conformation O
in O
vivo O
. O

Between O
the O
RNA O
initiation O
site O
and O
the O
coding O
region O
is O
a O
GC O
- O
rich O
hairpin O
structure O
followed O
by O
8 O
T O
residues O
that O
looks O
like O
a O
rho B
- I
independent I
transcription I
terminator I
. O

